# MERTK-Mediated LC3-Associated Phagocytosis (LAP) of Apoptotic Substrates in Blood-Separated Tissues: Retina, Testis, Ovarian Follicles

Marina G. Yefimova, Célia Ravel, Antoine D. Rolland, Nicolas Bourmeyster, Bernard Jégou

► To cite this version:

Marina G. Yefimova, Célia Ravel, Antoine D. Rolland, Nicolas Bourmeyster, Bernard Jégou. MERTK-Mediated LC3-Associated Phagocytosis (LAP) of Apoptotic Substrates in Blood-Separated Tissues: Retina, Testis, Ovarian Follicles. Cells, 2021, 10 (6), 10.3390/cells10061443. doi:10.3390/cells10061443

HAL Id: hal-03280904

https://hal.science/hal-03280904

Submitted on 7 Jul 2021

HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d'enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.

<figure><img src="image_1.png" /></figure>

Distributed under a Creative Commons Attribution 4.0 International License
Review

# MERTK-Mediated LC3-Associated Phagocytosis (LAP) of Apoptotic Substrates in Blood-Separated Tissues: Retina, Testis, Ovarian Follicles

Marina G. Yefimova 1,2,*, Celia Ravel 2, Antoine D. Rolland 3, Nicolas Bourmeyster 4,5 ID and Bernard Jégou 3

<figure><img src="image_2.png" /></figure>

check for
updates

**Citation:** Yefimova, M.G.; Ravel, C.; Rolland, A.D.; Bourmeyster, N.; Jégou, B. MERTK-Mediated LC3-Associated Phagocytosis (LAP) of Apoptotic Substrates in Blood-Separated Tissues: Retina, Testis, Ovarian Follicles. *Cells* **2021**, *10*, 1443. https://doi.org/10.3390/cells10061443

Academic Editors: Ryuta Koyama
and Kumiko Nakada-Tsukui

Received: 8 May 2021

Accepted: 7 June 2021

Published: 9 June 2021

**Publisher's Note:** MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

<figure><img src="image_3.png" /></figure>

**Copyright:** © 2021 by the authors.
Licensee MDPI, Basel, Switzerland.
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

**Abstract:** Timely and efficient elimination of apoptotic substrates, continuously produced during one's lifespan, is a vital need for all tissues of the body. This task is achieved by cells endowed with phagocytic activity. In blood-separated tissues such as the retina, the testis and the ovaries, the resident cells of epithelial origin as retinal pigmented epithelial cells (RPE), testis Sertoli cells and ovarian granulosa cells (GC) provide phagocytic cleaning of apoptotic cells and cell membranes. Disruption of this process leads to functional ablation as blindness in the retina and compromised fertility in males and females. To ensure the efficient elimination of apoptotic substrates, RPE, Sertoli cells and GC combine various mechanisms allowing maintenance of tissue homeostasis and avoiding acute inflammation, tissue disorganization and functional ablation. In tight cooperation with other phagocytosis receptors, MERTK—a member of the TAM family of receptor tyrosine kinases (RTK)—plays a pivotal role in apoptotic substrate cleaning from the retina, the testis and the ovaries through unconventional autophagy-assisted phagocytosis process LAP (LC3-associated phagocytosis). In this review, we focus on the interplay between TAM RTKS, autophagy-related proteins, LAP, and Toll-like receptors (TLR), as well as the regulatory mechanisms allowing these components to sustain tissue homeostasis and prevent functional ablation of the retina, the testis and the ovaries.

**Keywords:** Mer tyrosine kinase; phagocytosis; autophagy; LAP; retina; testis; ovaries

## 1. Phagocytosis, General Information, and Types of Phagocyte Cells

Every day, around 20–50 billion cells die by apoptosis and have to be eliminated from the body in order to maintain homeostasis and to avoid the autoimmune response against intracellular antigens [1,2]. Therefore, once formed, apoptotic cells and cell debris are immediately eliminated by cells endowed with phagocytic activity. Over the last few years, important progress has been made on the deep understanding of the different steps and molecular support of phagocytosis of apoptotic substrates. Several excellent reviews are available to date [3,4]; therefore, here we will only briefly touch upon the general information regarding phagocytosis process per se, and then focus on phagocytosis mediated by c-mer proto-oncogene tyrosine kinase (MERTK) in blood-separated tissues.

In the classical definition, phagocytosis is a complex, tightly regulated process, which consists of three principal steps: the recognition and binding of the substrate (step 1), followed by its internalization (step 2), and completion of the process by its degradation by lysosomes (step 3) [5]. A plethora of different receptors on phagocyte plasma membranes

<footnote n="1">¹ Sechenov Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences, 44, Prosp. Maurice Thorez, 194233 St-Petersburg, Russia</footnote>

<footnote n="2">² Département de Gynecologie Obstétrique et Reproduction Humaine—CECOS, CHU de Rennes, 16, Boulevard de Bulgarie, 35000 Rennes, France; Celia.RAVEL@chu-rennes.fr</footnote>

<footnote n="3">³ Univ Rennes, Inserm, EHESP, Irset (Institut de Recherche en Santé, Environnement et Travail)-UMR_S 1085, F-35000 Rennes, France; antoine.rolland@univ-rennes1.fr (A.D.R.); bernard.jegou@inserm.fr (B.J.)</footnote>

<footnote n="4">⁴ Laboratoire Signalisation et Transports Ioniques Membranaires, CNRS ERL 7003, Université de Poitiers, 1 rue Georges Bonnet, F-86022 Poitiers, France; nicolas.bourmeyster@univ-poitiers.fr</footnote>

<footnote n="5">5 Service de Biochimie, CHU de Poitiers, 1, rue de la Milétrie, 86021 Poitiers, France</footnote>

<footnote>* Correspondence: yefimova3@gmail.com</footnote>
recognize particular molecular markers on the surface of apoptotic substrates, thereby allowing their binding and the realization of step 1 of phagocytosis. Nevertheless, only a limited number of these receptors are responsible for target ingestion [6], which corresponds to step 2 of phagocytosis. The ingestion is not automatically triggered by the initial binding of the particle to the phagocyte; it requires sequential interaction of phagocyte receptors with ligands on the remainder of the particle's surface [7]. Moreover, ingested substrate cannot be directly addressed for degradation (step 3), but can accumulate in cell cytoplasms [8].

Depending on their origin (hematopoietic or not), the phagocytes are termed as professional or non-professional, respectively [9]. In a normal situation, freely circulating professional phagocytes from the bloodstream cannot infiltrate the blood-separated tissues. In this case, the resident cells of epithelial origin act as non-professional phagocytes, providing the clearance of tissue-specific substrates. This contributes to tissue homeostasis; therefore, such a type of phagocytosis is termed as homeostatic phagocytosis [10].

## 2. Non-Professional Phagocytes from Blood-Separated Tissues and Their Substrates

Among blood-separated tissues, the retina, the testis and the ovaries manifest the highest rate of the production of apoptotic substrates, therefore requiring efficient machinery for their removal.

Thus, in the eye, numerous portions of the retinal photoreceptor cell membrane (packaged into discs) are shed daily from living photoreceptors and ingested by retinal pigmented epithelium (RPE) cells [5,11]. In rats, each RPE cell contacts about 250-300 photoreceptor outer segments (POS), and each RPE ingests some 25,000-30,000 disks every day [12]. It has been estimated that in 80 years old humans, each single RPE cell will have engulfed some 108 shed POS [13].

In the mammalian testis, germ cell death is a prominent event during normal spermatogenesis. As estimated, it results in the loss of up to 75% of the potential number of mature spermatozoa [14,15]. Furthermore, $250 \times 10^6$ residual bodies (RB), which are the fragments of apoptotic membranes detached from elongated spermatids [16], are produced daily by the mammalian testis. Both apoptotic germ cells and RB are ingested and destroyed by the somatic Sertoli cells [17,18], which are "nurse" cells of the testis, forming a part of a seminiferous tubule and supporting the process of spermatogenesis [19].

The ovary is also an extremely dynamic organ, in which 99% of ovarian germ cells undergo apoptosis through follicular atresia [20]. An ovarian follicle, which is a basic unit of female reproductive biology, consists of single oocyte surrounded by a layer of GC and enclosed in basal lamina. Apoptotic death affects oocyte at primordial, primary and small preantral phases of follicle maturation. Elimination of apoptotic oocytes relies upon phagocytic activity of GC [21], which share striking similarities with testis Sertoli cells with respect to their origin and function. According to the standard model of sex determination, both the Sertoli cells and the GC directly stem from the supporting cell precursors of the bipotential gonad [22].

## 3. Autophagy: A Lysosome-Related Degradation Pathway Sharing Similarities with Phagocytosis

Degradation of ingested substrates by phagocyte cells relies upon the hydrolytic activity of lysosomes. Lysosomes are also involved in the degradation of intracellular components through autophagy machinery. Autophagy was classically defined as the starvation survival mechanism, endowing cells with the ability to auto digest. This mechanism allows the degradation and reuse of the portions of cell cytoplasm in support of vital functions [23,24]. In the past, autophagy was considered a non-selective process by which randomly enclosed cargo was degraded in bulk. However, recent findings suggest that autophagy is a highly selective process, specifically targeting cellular organelles and cytoplasmic components, such as mitochondria, ribosomes, peroxisomes, lipid droplets, misfolded proteins, and intracellular pathogens [25]. Autophagy participates in a broad spectrum of biological processes, including ageing, development, degenerative diseases
and cancer, being triggered by variety of stimuli both in vitro and in vivo [26]. Autophagy is heralded by the formation within the cytosol of crescent-shaped nascent autophagic isolation membranes (phagophores) that corral cytoplasmic targets into short-lived double membrane autophagosomes. After maturation and fusion with a lysosome, the captured cargo is exposed to the degradative lysosomal enzymes [27] that decompose large molecules into their basic units. Autophagy has a nearly unlimited degradative capacity. It can target proteins, lipids, both DNA and RNA as well as entire organelles, thereby providing new pools of amino acids, fatty acids and nucleosides for anabolic processes [28]. To date, 37 autophagy-related genes (ATG) have been identified in yeast, with orthologues well conserved throughout eukaryotes [29].

A range of signaling processes converge on two protein complexes to initiate autophagy: the ULK1 (Unc-51 like autophagy activating kinase 1) protein kinase complex and the PI3KC3-C1 lipid kinase complex [30]. The ULK1–Atg13–FIP200 (FAK family kinase-interacting protein of 200 kDa) complex regulates autophagosome synthesis downstream of the mTOR (mechanistic target of rapamycin) signalling pathways. The PI3KC3 complex, comprising hVps34, Beclin-1 and hVps15, also regulates autophagosome synthesis, possibly downstream of the mTOR-independent pathways. A key regulatory mechanism of autophagy is that Beclin 1 is complexed with Bcl-2 family proteins; the dissociation of Bcl-2 from the Beclin 1-hVPS34 complex activates autophagy [31,32]. The dissociation of the Bcl-2–Beclin 1 complex is regulated by kinases, tumor suppressors [27], as well as key adapter proteins in innate immunity signaling downstream of TLRs, such as MyD88 and TRIF [33]. Several Beclin-1 interactors, such as Atg14L, UVRAG (UV radiation resistance-associated gene protein), Bif-1 (Bax-interacting factor 1) and Ambra1 (Autophagy and Beclin 1 Regulator 1), or Rab5 (Ras-related protein 5) interacting with hVps34, positively modulate this process. Two ubiquitin-like conjugation systems involving Atg proteins function in the elongation of phagophores. The Atg5–Atg12 conjugation involves Atg7 and Atg10, whereas the LC3–PE (Microtubule-associated protein 1A/1B-light chain 3—Phosphatidylethanolamine) conjugation involves Atg7 and Atg3. The Atg5–Atg12 conjugate forms a complex with Atg16, Atg5–Atg12·Atg16, which demonstrates E3-like (ubiquitin ligase) activity towards LC3–PE conjugation (LC3-II). LC3-II is a specific autophagy marker currently used to monitor autophagy [34].

4. Autophagy in Non-Professional Phagocytes from Blood-Separated Tissues

Autophagy degradation machinery plays a significant role in homeostasis maintenance in RPE, GS and Sertoli cells. A high basal autophagy level is maintained in RPE cells, and the light exposure causes an autophagic response in mice [35–39]. Several experimental studies indicate that compromised autophagy in RPE cells is associated with early signs of retinal degeneration [40–42], and impairing autophagy leads to RPE apoptosis [42]. RPE from patients with late stages of age-related macular degeneration (ARMD) manifest decreased levels of autophagy proteins, suggesting their role for normal ocular physiology [36]. Autophagy was shown to protect RPE cells from the toxic effects of oxygen peroxide and ethanol treatments, while inhibition of autophagy abolished the protective effect [40,41].

A high basal level of autophagy has also been detected in Sertoli cells [43,44], wherein it supports several basal physiological processes. Thus, autophagy is implicated in the testosterone-regulated clearance of androgen-binding proteins (ABP) [45]. Testosterone-induced upregulation of ABP expression is thought to be related to the suppression of autophagic degradation of ABP. The knocking down of autophagy genes in Sertoli cells increases germ cell apoptosis, reduced spermatozoa count and abnormal spermiation [46]. A protective effect of autophagy for Sertoli cell survival has been demonstrated in acute ethanol-induced exposure in rodents [47,48]. In contrast to germ cells, which undergo apoptosis after ethanol exposure, Sertoli cells resist apoptosis through the upregulation of autophagy at the spermiation stages of the spermatogenic cycle [47,48]. Moreover, following acute ethanol exposure, numerous apoptotic germ cells and spermatozoa are
found within the cytoplasm of Sertoli cells, indicating the role of autophagy proteins in the cleaning of seminiferous tubules from apoptotic substrates [47,48].

The expression of autophagy proteins in GC has been detected by numerous teams [49]. Experimental evidence indicates that autophagy is involved in the processes of follicular growth and atresia [49]. Mice with *Atg7* gene knockdown typically produce small litters and become sterile over time [50]. The ovaries of *Atg7*-deficient mice always contain fewer germ cells and primordial follicles; the latter are often structurally altered and non-functional. In vitro autophagy in GC is modulated by gonadotropin treatment [51,52], and the exposure of GC to oxidized low-density lipoprotein [53]. In vivo, the activation of mTOR mediated by AKT suppresses GC autophagy during follicular atresia in rats [54], suggesting the crucial role of autophagy for female gametogenesis.

## 5. Non-Canonical Roles of Autophagy

Recent evidence has established that a variety of non-canonical functions of autophagy proteins are mechanistically and functionally distinct from autophagy [55]. Several autophagy proteins from canonical autophagy machinery are used in separate processes, such as LANDO (LC3-associated endocytosis pathway), which is involved in the recycling of amyloid receptors and in the clearance of amyloid aggregates by microglia in a murine model of Alzheimer's Disease (AD) [56]; CUPS (compartment for unconventional protein secretion) for unconventional secretion of proteins without signal peptides as acyl-CoA binding protein 1 and interleukin-1β [57–61]; DRibbles (Defective Ribosomal Products-Containing Autophagosome-Rich Blebs)-for secretion of exosome-like fractions modified by autophagosomes [62–64]; and LAP (LC3-associated phagocytosis) - a hybrid process, in which autophagy proteins support phagocytosis degradation machinery [55] (see below, § 9).

## 6. Ablation of Phagocytic Activity by Resident Non-Professional Phagocytes Causes Blindness in the Retina and Compromised Fertility in the Testis and the Ovaries

To date, the notion of the importance of homeostatic phagocytosis for functional consistency of blood-separated tissues is widely accepted. Ablation of phagocytic ability by resident non-professional phagocytes has been shown to cause dramatic outcomes for blood-separated tissues, including the loss of their specific functions and their degeneration. This was first demonstrated in a genetic model of retinal degeneration in Royal College of Surgeons (RCS) rats. This naturally occurring rat strain was described in the first half of the 20th century [65]. Subsequent long-term study of this model showed that an irreversible blindness in RCS rats was caused by the inability of retinal pigmented epithelium to ingest the tips of POS shed from photoreceptor cells in vivo and in vitro [66]. The pattern of degeneration in RCS rats has been thoroughly documented using histological and electron-microscopy techniques (Figure 1). Thus, it was established that by 3 weeks of age, photoreceptor outer segments showed evidence of disruption with the development of an apical debris zone. By 4 weeks, pyknotic photoreceptor nuclei were observed in the outer nuclear layer. Between 7 and 12 postnatal weeks, the outer nuclear layer was reduced to a single layer of photoreceptor cell bodies and the debris zone occupied the former outer segment area [67,68]. TUNEL staining indicated that apoptosis was the dominant mechanism of photoreceptor degeneration in the RCS [69]. Further deterioration of the debris zone allows the inner nuclear layer to come into close contact with RPE by 24 weeks of age. Secondary neurodegenerative changes include the loss of retinal ganglion cells, withdrawal of bipolar cell axons, Müller cell gliosis, neuronal sprouting of horizontal cells and microglial activation [67,68,70,71]. To date, the RCS rat provides a model to study various cellular interactions and triggering mechanisms leading to this secondary photoreceptor cell death. There is not an uniform opinion on the cause of photoreceptor cell death. Thus, the debris zone acting as a diffusion barrier to metabolite, disruption of the interphotoreceptor matrix, photoreceptor hypoxia due to diminished oxygen diffusion, and gradual accumulation of toxic iron deposits in the layer of photoreceptor debris have been proposed as possible explanations [72,73]. The latter explanation concerns iron ions released from the iron-transport protein transferrin, which undergoes a non-specific degradation in
the debris zone. In normal retina, transferrin is secreted by RPE cells in order to deliver this vital element to photoreceptor cells [73,74]. The degradation of transferrin results in the liberation of iron ions which accumulate in debris zone. This triggers oxidative stress [75], which contributes to the apoptotis of photoreceptors [69,76]. Intravitreal injections or non-viral delivery of transferrin in its iron-free form (apotransferrin) to chelate unbound iron, or antioxidant biomolecules, delay retinal degeneration in RCS rats, supporting the consistency of such a scenario [75–77].

<figure><img src="image_4.png" /><figcaption>**Figure 1.** Degenerative changes in RCS rat retina and in the testis of triple mutant TAM-/– mice. Abbreviations: GCL—ganglion cell layer, INL—inner nuclear layer, ONL—outer nuclear layer, RPE—retinal pigmented epithelium, SC—Sertoli cells, GC—giant cell.</figcaption></figure>

In 2000, two independent research groups concurrently identified a single gene defect, the *Mer* tyrosine kinase (*Mertk*) [78–80]. The deletion in the *Mertk* cDNA [79], resulting from a large genomic deletion [78], led to the production of non-functional 20-amino-acid Mertk proteins in RPE cells. The latter failed to internalize POS. Subsequent studies demonstrated that transgenic (*Mertk KD*) mice developed the same phenotype as RCS rats [81], resembling the symptoms of retinitis pigmentosa patients. Mutations of *Mertk* in humans were shown to be associated with retinitis pigmentosa and other ocular pathologies [82,83]. Further studies demonstrated that the subretinal injection of a recombinant replication-deficient adenovirus encoding rat *Mertk* to the eyes of young RCS rats caused the substantial sparing of photoreceptors, preservation of the outer segment structure, and correction of the RPE phagocytosis defect in areas surrounding the injection site [72]. Electrophysiological assessment of animals 30 days after injection revealed the increased sensitivity of treated eyes to low-intensity light. These results provided definitive evidence that the mutation of *Mertk* underlies the RCS retinal dystrophy phenotype, and that the phenotype can be corrected by the treatment of juvenile animals [72].

In parallel with ocular studies throughout the last decade of the 20th century, another research team specialized in reproduction biology generated and analyzed null mutations in the mouse genes encoding three structurally related receptors with tyrosine kinase activity: *Tyro 3*, *Axl*, and *Mer* (TAM family) [84]. These mice presented increased apoptosis and cellular degeneration in a variety of adult tissues; however, only two adult tissues were found to manifest complete loss of specific function, namely the testis and the retina. TAM-/- triple mutants were blind due to degeneration of photoreceptor cells; the adult males were sterile, never siring offspring. The testes of adult mice were one-third of the size of those of wild type (WT) ones, seminiferous tubules presented perturbed cellular organization, and epididymis was invariably devoid of sperm (Figure 1). Further study
revealed no evidence of impaired proliferation of spermatogonia in adult *TAM*−/− mice, but detected increased germ cell apoptosis and an emergence of giant cells in seminiferous epithelium. Consistent with the loss of germ cells, the seminiferous tubule diameter was significantly decreased in *TAM*−/− mice at 15 weeks of age and older, reflecting a decrease in total germ cell complement. Extensive study of seminiferous tubule sections allowed the conclusion that, in *TAM*−/− mice, the germ cells were progressively lost from elongated spermatids to spermatocytes, and finally, the observation of spermatogonia as the mice aged. Furthermore, young adult *TAM*−/− mice exhibited oligo-astheno-teratozoospermia and various morphological malformations of sperm cells [85,86]. *TAM* double mutants were also compromised with respect to spermatogenesis, although to a lesser extent; among double mutant mice, the *Tyro3*−/*Axl*−/*Mer*/+ phenotype was less severe with respect to fertility and testicular size, and all single mutant males appeared normal. Of note is that *Mer*−/− mutants were blind [84]. Maturation and functions of testosterone-producing Leydig cells were not apparently affected in *TAM*−/− mice, as well as serum testosterone levels [85,86]. Subsequent in situ hybridization (ISH) study revealed that mRNA for TAM receptors was confined to the Sertoli cells during postnatal development [84]. Because no TAM expression was detected in germ cells, it was concluded that impaired spermatogenesis should not be germ cell autonomous, but relies upon a functional disability of Sertoli cells which are critical for normal spermatogenesis [87].

Though the authors of this original paper [84] did not discuss spermatogenesis failure as a consequence of phagocytosis defected by Sertoli cells induced by TAM mutation, subsequent studies by other research teams shed light on this causative link [85,86]. Using primary culture of Sertoli cells isolated from the testis of TAM mutant mice, the rate of phagocytosis of apoptotic germ cells was assessed for single, double or triple mutant. The data obtained indicated that Sertoli cells lacking Mertk showed a 35% reduction in phagocytosis rate, whereas cells lacking Tyro3 or Axl exhibited no reduction in comparison to WT control. Sertoli cells from triple TAM mutants showed a dramatic decrease in phagocytosis rate of 7.6-fold when compared to the wild type Sertoli cells [85,86]. Collectively, the data presented the first experimental evidence for the importance of TAM receptors for phagocytosis function by Sertoli cells in vitro.

The defect of Sertoli cell phagocytosis is currently considered a major cause of the impaired spermatogenesis in TAM mutant mice [85–89]. One explanation for how the timely removal of apoptotic cells and residual bodies contributes to spermatogenesis is the prevention of leaking out noxious contents and poisoning healthy cells [88]. Another explanation concerns energy balance in seminiferous tubules. As evidenced, the apoptotic spermatogenic cells and residual bodies could be used to produce energy by Sertoli cells after the phagocytosis of them [90]. The net output of energy by Sertoli cells is important not only to spermatogenesis, but also to germ cell movement [91]. Impaired Sertoli cell phagocytosis may result in a decrease in the energy production by Sertoli cells as well.

Studies on *TAM*−/− triple mutant mice also revealed reduced fertility in females [84], but this finding remained unnoticed for years. To our knowledge, there is no literature data depicting ovarian histology in *TAM*−/− mutant mice. The idea of the involvement of GC in removing apoptotic oocytes emerged from transcriptomic analysis of bovine GC from small antral follicles undergoing atresia. Indeed, a 4-fold increase of Mertk expression was detected in GC, surrounding small antral follicles [92]. A subsequent study confirmed the role of GC in the removal of apoptotic oocytes through MERTK-mediated phagocytosis [21]. Further investigation is needed to clarify a possible scenario leading to compromised fertility in females carrying mutation in the *MERTK* gene, and its relationship with phagocytosis by GC.

7. MERTK Is a Member of the TAM Family of Receptor Tyrosine Kinases

The TAM family of receptor tyrosine kinases (RTKs) includes Tyro3, Axl and Mer
members which share similarities in structure and function. TAM receptors are expressed
in many cell types, but the pattern of individual receptor expression varies. Mer is highly
expressed in monocytes/macrophages, testis, ovaries and epithelial cells (including the RPE) [93–95].

In recent years, several signaling functions of TAM receptors have been described, such as stimulation of cell growth and proliferation, inhibition of apoptosis, stimulation of hemostasis, modulation of inflammation and phagocytosis of apoptotic substrates by professional [96,97] and non-professional phagocytes [98]. In professional phagocytes, the requirement of each member of the TAM family depends on the type of phagocyte: in macrophages, Mer is essential for rapid ingestion of apoptotic cells, though Axl and Tyro3 are partly involved. In dendritic cells, Axl and Tyro3 appear to function, and Mer has no role [97,99]. In microglia, Axl and Mer, but not Tyro3, are implicated in apoptotic substrate phagocytosis [100].

TAM are transmembrane proteins composed of an extracellular region, containing two immunoglobulin-like (IG-like) domains, linked to two fibronectin type III repeats and a cytoplasmic region containing a protein tyrosine kinase domain [101]. TAM receptors may signal either in response to ligand activation or by formation of homodimers or heterodimers with each other or other receptor tyrosine kinases to signal independently of their ligands [102–104]. Ligand binding to the extracellular domain induces receptor dimerization and the subsequent trans-autophosphorylation of tyrosine residues within the cytoplasmic domain. This results in the subsequent activation of the complex cascade of signaling molecules [105]. To date, at least five different molecules, namely Growth Arrest Specific protein 6 (GAS6), Protein S (PROS1) [106], tubby, Tulp1 [107] and galectin 3 (Gal3) [108], have been described as TAM ligands.

Among TAM ligands, GAS6 and PROS1 recognize the apoptotic marker phosphatidylser-
ine (PS) exposed on the outer membrane leaflet of the apoptotic membrane [109]. TAM
ligands bridge apoptotic substrate to TAM receptors on the plasma membrane of the
phagocyte. Almost all of bridging molecules are expressed by blood-separated retina, testis
and ovaries, suggesting the importance of TAM signaling in these tissues [84,109–119].
Moreover, data from animal models indicate that, in the testis, such multiligand bridging
provides the phagocytic clearance of apoptotic substrates even when one and/or two of
the bridging molecules are knocked down (Gas6-/- mice [120], double KO Gas6/ProS-/-
mice [121], Gal3-/- mice [122], and Tub null mice [123]). In the case of double KO mice,
such functional compensation seems to provide an advantage for the Sertoli cell (and
probably for GC) over RPE cells which also use TAM RTKs to maintain tissue homeostasis.

8. MERTK Cooperates with Other Phagocytosis Receptors to Provide the Ingestion of Apoptotic Substrates

Phagocytosis of apoptotic substrates by RPE, testis Sertoli cells and ovarian GC is associated with the activation of MERTK [21,44,124,125]. Nevertheless, studies from TAM mutant mice showed that homeostatic phagocytosis machineries from testis and ovaries were able to maintain phagocytic function even when some of the receptors were knocked down [84]. On the contrary, phagocytosis by RPE cells was completely arrested in *Mertk* -/- mice [81], suggesting the pivotal role of this receptor for maintaining ocular homeostasis and visual function.

Phagocytosis by RPE cells has been extensively studied by numerous teams, so the
main events allowing POS to be ingested by RPE cells have been established. Though
having a primordial role in POS phagocytosis, Mertk cooperates with Tyro3 [126] and other
surface-bound receptors, which provide tight attachment of POS to the phagocyte plasma
membrane and trigger downstream signaling. POS detached from photoreceptor cells are
“apoptotic-like” substrates exposing PS, which binds to the cluster of differentiation 36
(CD36) on apical membranes of RPE cells [127]. Furthermore, the αVβ5 integrin receptor
also binds POS by bridging milk globular factor E-8 (MGF-E8) protein secreted by RPE
cells. The binding of POS to αVβ5 integrin receptors stimulates both MERTK (through
αVβ5 integrin-associated focal adhesion kinase (FAK) [128]) and Ras-related C3 botulinum
toxin substrate 1 (RAC1)-GTPase [129], leading to actin recruitment to the phagocytic
cup. Moreover, Mertk is also activated after binding with GAS6 and/or PROS1 bound
to POS. Activation of RAC1-GTPase downstream of Mertk phosphorylation has also been demonstrated for testis Sertoli cells during phagocytosis of apoptotic substrates [44]. In RPE, phosphorylation of Mertk generates docking sites for phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3) kinases [130], which is required for the recruitment of F-actin to the phagocytic cup [127]. Besides, Mertk signaling induces the recruitment of myosin II to close the phagocytic cup and to move apoptotic substrates inside phagocytes as demonstrated for RPE, GC and Sertoli cells [21,44,124].

To date, no information on multireceptor complexes providing membrane remodeling and ingestion of apoptotic substrates in testis and ovaries is available. Nevertheless, the scavenger receptor CD36 [131] and integrins and bridging molecules GAS6, PROS1 and MGF-E8 are expressed in testis and ovaries [132–136]. Moreover, the translocation of the CD36 receptor across the Sertoli cell towards the sites of accumulation of RBs and apoptotic germ cells has been shown both in vitro and in vivo [131]. CD36 is highly expressed in GC [137], and CD36 null mice display ovarian morphology resembling those seen in polycystic ovarian syndrome (PCOS), in which there is an abnormally increased number of primary follicles which remain preovulatory [138]. Furthermore, the variations of FAK phosphorylation and RAC1-GTPase driven actin re-arrangement depending on various stages of seminiferous epithelium and ovarian cycles have been detected as well [139–142]. Further studies are needed to identify the member of phagocytosis machinery providing the cleaning of apoptotic substrates in testes and ovaries.

## 9. MERTK-Mediated Phagocytosis in Blood-Separated Tissues Is an Autophagy-Assisted Process Termed LAP

In 2013, two independent studies demonstrated that homeostatic phagocytosis machinery in the retina and in the testis required the involvement of autophagy-related proteins [44,143]. These data were further supported by [18,21], who confirmed the recruitment of autophagy-related proteins for apoptotic substrate cleaning in the testis and in the ovaries.

It has been established that the phagosomes formed downstream of MERTK activation in RPE, Sertoli and GC contained several autophagy markers, including lipidated LC3 protein [21,44,143]. These unconventional phagosomes were produced following the activation of LC3-associated phagocytosis (LAP), a "hybrid" process in which autophagy proteins supported phagocytosis machinery. Exploitation of the autophagy component increases the efficiency of phagocytosis, providing rapid lysosomal fusion and cargo degradation. Mice that are deficient for LAP, but not for canonical autophagy, accumulate apoptotic bodies within the cytosol of phagocytic cells [144]. The unconventional phagosomes containing LC3 proteins were termed LAPosomes. In contrast to autophagic vacuoles, the LAPosomes are single-membrane vesicles coated with lipidated LC3 protein [144].

LAP is a separate process, which strongly differs from both phagocytosis and autophagy. A major difference between LAP and classical phagocytosis is the accumulation of the lipidated form of the LC3 protein (LC3-II) during the intracellular management of apoptotic substrates. In macrophages, LAP is triggered by the engulfment of pathogens, immune complexes, and dying cells via engagement of Toll-like receptors (TLRs), Fc receptors (FcRs), and phosphatidylserine receptors (PtdSer-Rs) [145]. LAP-specific genes include ATG5, autophagy-related gene 7 (ATG7), Beclin1, Rubicon (RUN domain and the cysteine-rich domain containing Beclin 1-interacting protein) and NOX2 (NADPH oxidase-2) [146,147]. The protein Rubicon acts as a molecular switch between the repression of autophagy and the activation of LAP [146]. While using several autophagy proteins, LAP is independent of the autophagy preinitiation complex (ATG13-ULK1 (Unc-51 like autophagy activating kinase 1)-RB1CC1/FIP200 (RB1 inducible coiled-coil 1)-ATG101) [143,147,148]. In macrophages and in retinal pigmented epithelial cells, autophagy components ATG5, ATG7, ATG3, ATG12, ATG16L1 and a Beclin1-PIK3C3 (Phosphatidylinositol 3-Kinase Catalytic Subunit Type 3)/VPS34 (vacuolar protein sorting) complex lacking ATG14 are engaged in the lipidation of LC3 protein and its recruitment to the phagosome. LAP also requires Rubicon for proper function [146,149]. During LAP, Rubicon is recruited to the LAPosome and is required for the activity of a PI3KC3 complex containing Beclin-1, UV ra-
diation resistance-associated gene protein (UVRAG), and VPS34, but lacking the canonical autophagy components ATG14 and activating molecule in BECN1-regulated autophagy protein 1 (Ambra1). LC3, Beclin1, ATG5 and Rubicon proteins have been detected in LAPosomes from different types of phagocytic cells (blood macrophages, RPE cells, GC) that use LAP [21,44,144,146,150–152]. LC3, Beclin1, ATG12 and Rubicon proteins have been detected in LAPosomes formed by the Sertoli cells [18].

10. LAP Is a Degradation Process Different from Both Phagocytosis and Autophagy

TAM RTKs have been shown to trigger LAP in professional phagocytes after binding to PS on apoptotic substrates through bridging molecules such as GAS6 or ProS1. Alternatively, LAP is initiated upon the engulfment of apoptotic cells through T cell/transmembrane, immunoglobulin, and mucin (TIM)-1,3,4 receptors, or stabilin-1, stabilin-2 and brain-specific angiogenesis inhibitor (BAI1) receptors. LAP is also engaged by TLR receptors 1/2, TLR2/6 and TLR4 (see below) [144]. The presence of LC3 proteins distinguishes LAPosomes from single membrane phagosome vesicles [144]. LAP is also often termed as non-canonical autophagy [153] (Figure 2).

<figure><img src="image_5.png" /><figcaption>**Figure 2.** Phagocytosis, autophagy and LAP are functionally and mechanistically distinct degradative pathways.</figcaption></figure>

A major difference between LAP and conventional autophagy is the very short time taken for the accumulation of a lipidated form of LC3. Indeed, the lipidation of LC3
protein can be detected 15 min after the loading of an apoptotic substrate to a phagocyte cell [21,24,143]. Furthermore, 30 min after the binding of an apoptotic substrate to a plasma membrane, the LAPosome fuses with lysosomes, triggering a degradation process, as shown for RPE cells [154]. Such a high rate of LAP explains the interesting phenomenon regarding the absence of apoptotic germ cells from the sections of seminiferous tubules. Indeed, in the seminiferous tubules, germ cell death undergoes cyclic variations depending on the stage of the seminiferous epithelium cycle [19]. Nevertheless, neither massive presence nor cyclic variation of died germ cells in tissue sections and within the Sertoli cell cytoplasm has been detected [155,156]. To explain this fact, it has been hypothesized that the phagocytic elimination of apoptotic germ cells in the seminiferous tubules is a special, extremely fast process, which was unknown at that time [156]. Nowadays, the involvement of LAP in apoptotic germ cell cleaning is well documented [18]. Of note is that other substrates for removal by Sertoli cells (i.e., spermatid's RB) seem to be processed through conventional phagocytosis machinery because their management does not involve LC3 recruitment [44].

LAP and autophagy share many cellular resources, using common mediators such as ATG5, ATG7, LC3 and BECN1, and compete for lysosomes to provide cargo degradation [149]. In rodent RPE under physiological conditions, Mertk-MERTK-mediated autophagy-assisted phagocytosis and autophagy processes reach their peak at different times of day. This avoids the competition for lysosomal resources in vivo [149] and suggests a balance between autophagy and LAP in non-professional phagocytes. Indeed, starvation-induced autophagy impairs the degradation of POS [143,149]. In vitro study using a chimerical phagocytosis model, in which ovarian GC were used as non-professional phagocytes and retinal POS as apoptotic-like substrates, showed that the induction of autophagy influences the uptake of POS [21]. Indeed, the induction of autophagy by rapamycin treatment in GC dramatically decreased the number of ingested POS, while the number of bound ones presented no variation. Remarkably, in contrast to large pieces of bound POS, the POS ingested by GC were fragmented into small particles. The latter were almost absent from rapamycin-treated GC, suggesting that autophagy induction influences the processes of MERTK-mediating ingestion and/or fragmentation of apoptotic substrates by non-professional phagocytes. The role of the Rubicon protein providing the switch between autophagy and LAP seems likely to support such a mechanism [146] (Figure 3).

A recent study [154] using human pluripotent stem cell-derived RPE cells shed light on the role of MERTK in the fragmentation of POS. Indeed, in RPE cells, phagocytosis starts with the capture and ensheathment of POS by apical processes of RPE. The phagosomes/LAPosomes then ascend in the processes toward the RPE soma [157]. Ensheathment was stimulated by MERTK ligands, GAS6 and PROS1, but not by αVβ5 integrin receptor ligands, MFG-E8 and vitronectin. Remarkably, the ensheathment participates in fragmenting POS before their internalization. The authors suggest that this is necessary to "bite-off" POS fragments as eatable-sized portions from the photoreceptors, and that MERTK activation is required for ensheathment-mediated fragmentation of POS before internalization [154]. Moreover, the knocking down of MERTK in RPE resulted in complete failure of the ensheathment, fragmentation and internalization of POS, thereby leading to vision loss in patients and animal models. The rescue of MERTK expression in retinitis pigmentosa (RP38) patient RPE counteracted these defects [154]. The molecular mechanism downstream of MERTK activation which leads to fragmentation of apoptotic substrates remains to be uncovered. Knowledge of this mechanism would shed light onto the mode of fragmentation of large substrates, such as apoptotic germ cells or apoptotic oocytes, before their cleaning by non-professional phagocytes from testis and ovaries.
<figure><img src="image_6.png" /><figcaption>**Figure 3.** Elimination of apoptotic substrates in blood-separated retina, testis and ovaries. In each organ, specific non-professional phagocyte cells are in charge of the elimination of apoptotic substrates: Sertoli cells for germ cells in the testis, retinal pigmented epithelium cells for POS in the retina, and granulosa cells for apoptotic oocytes in ovarian follicles. In each case, and even for granulosa cells or Sertoli cells challenged with chimerical substrates (POS), LAP is triggered through the activation of different receptors recognizing specific molecules on the surface of apoptotic substrates. Among those receptors, MERTK plays a central role, allowing both the triggering of actin reorganization through Rho-GTPases, leading to engulfment of substrates, and assembling complexes of proteins accomplishing LAP. Abbreviations: LAP—LC3-associated phagocytosis; POS—photoreceptor outer segments, RB—spermatid's residual bodies; AO—Apoptotic Oocyte; AGC—Apoptotic Germ Cell.</figcaption></figure>

**11. Klotho Is a Regulator of MERTK Expression**

Because TAM tyrosine kinases are implicated in a variety of cellular metabolic pathways, the issue of regulation of their activities is of particular importance in several pathological states such as cancer and others. Therefore, different pharmacological modulators of TAM receptors have been elaborated [158]. Along with natural the TAM ligands listed above, these molecules can be used to target TAM receptors in different tissues.

To date, current knowledge on TAM receptor expression in human cells remains partial [159]. In the context of the present review, of special interest are the data on the regulation of MERTK expression by putative anti-aging gene Klotho (KL) [160,161].
The Klotho (Kl) gene was first described in 1997 [160]. The study demonstrated that Kl-null mice displayed phenotypes resembling human premature-aging syndromes. Klotho is a transmembrane protein, which can be cleaved and shed, as well as act as a circulating hormone [160]. Klotho can be isolated from bodily fluids, including blood, urine and cerebro-spinal fluid (CSF) [162].

Studies of the Kl-/- mice phenotype supported the importance of TAM family receptors for the maintenance of tissue homeostasis in the retina, the testis and the ovaries. In retinal health and RPE physiology, Klotho was shown to play a key role [161]. Studies on the retinal Kl-/- mice phenotype revealed retinal degeneration associated with RPE abnormalities. Phagocytosis of POS by RPE was dramatically impaired, so that no phagosomes were detected in RPE of Kl-/- mice [161]. Further studies showed that the Klotho protein was expressed in cultured human RPE, taking part in the regulation of melanogenesis. Moreover, recombinant Klotho proteins increased phagocytosis in cultured RPE by inducing gene expression of MERTK/Axl/Tyro3 receptors. These effects of Klotho are mediated through cAMP-PKA-dependent phosphorylation of transcription factor CREB [161]. Of interest is that the qRT-PCR study of retinas from young and old mice revealed a significant decrease of expression of Klotho and Mer/Axl/Tyro3 in old mice compared to young mice. This is in good agreement with the age-dependent decrease of phagocytic activity of RPE, increased lipofuscin content and the loss of vision in elderly individuals and animal models [163,164].

Remarkably, Kl-/- mice also manifest severe degeneration of reproductive organs in both males and females [160]. In normal human testes, Klotho is expressed by somatic Sertoli cells [165], while in mice, Klotho expression is mainly confined to germ cells [166]. Of note is that the ovaries of Kl-/- mice manifested a cessation of follicular maturation at the pre-antral stage, and the presence of numerous atretic ovarian follicles—a feature of human polycystic ovarian syndrome (PCOS) [167]. As recently shown in humans, PCOS is associated with abnormal Klotho signaling [168]. In human ovaries, Klotho is expressed by GC [169]. Furthermore, inhibition of Klotho expression in ovarian GC by miR-15b induces premature ovarian failure (POF) syndrome [170], which is heralded by the abnormal depletion of ovarian reserve. Moreover, in both GC and serum derived from women with diminished ovarian reserve, Klotho expressions were significantly lower compared to normal individuals [170]. Of note is that both PCOS and POF are associated with the presence of autoantibodies against ovarian antigens [171,172], indicating the failure of timely and complete removal of apoptotic substrates from the ovaries. Thus, the data from the Klotho phenotype in ovaries are in agreement with the role of MERTK-mediated cleaning of apoptotic substrates by GC.

## 12. TAM Receptors as Negative Regulators of Inflammation: Two Possible Explanations

A study on triple mutant TAM-/- mice revealed severe consequences in the immune system, resembling the pathogenesis of systemic lupus erythematosus (SLE) [173]. This was manifested by a high titer of circulating antibodies to multiple autoantigens, including double-stranded DNA, a variety of plasma membrane phospholipids and collagen. In addition to developing autoimmunity, TAM deficient mice are hyper-sensitive to endotoxins, as demonstrated by the production of pro-inflammatory cytokines; for example, Mer-/- mice die from a dose of lipopolysaccaride (LPS) that is non-lethal in WT control [174,175].

Two possible explanations of this phenomenon have been proposed, the first of them is based on the involvement of TAM receptors in the LAP-mediated mechanism of apoptotic substrate elimination. Indeed, the similar SLE-like phenotype was described for mice lacking one or several components of the LAP pathway, triggered (among others) by the activation of TAM receptors [176,177]. Remarkably, dying cells, injected into LAP-deficient animals, are ingested by immune cells, but not efficiently degraded, and trigger acute elevation of pro-inflammatory cytokines. Repeated injections of apoptotic cells into LAP-deficient animals accelerated SLA-like diseases, including increased serum levels of autoantibodies [176].
A study using dystrophic RCS rat model with Mertk mutation showed that retinal autoantibodies were generated in response to antigenic material released from dying photoreceptor cells during retinal degeneration [178]. The excess of apoptotic germ cells, impairment of the blood-testis barrier, macrophage and lymphocyte infiltration, along with the emergence of autoantibodies against germ cell antigens, are also the hallmarks of seminiferous tubules from *TAM*−/− mice [179–181].

The second explanation regards the TAM-mediated inhibition of the TLRs-induced inflammatory cascade. The TLR family plays an essential role in activating signal transduction pathways leading to the killing and clearance of pathogens [182]. TLRs are expressed by immune cells, such as lymphocytes, dendritic cells and macrophages, and non-immune cells such as epithelia cells of many tissues. Different members of the TLR family are expressed in RPE, Sertoli cells and GC [183–185]. Activation of TLRs elicits host defense factors responsible for local inflammation, the recruitment of immune cells and the secretion of cytokines that modulate innate and adaptive immune responses [186]. Failure of the TLR fine tuning causes their unrestrained activation, generating an inflamed environment promoting autoimmunity [187]. Therefore, negative regulation of TLR signaling is tightly controlled on multiple levels [188], including those of degradation of signal proteins, mediated by the suppressor of cytokine signaling (SOCS). Evidence indicating that TRLs are the subjects of negative TAM regulation, mediated by SOCS, was firstly presented for professional phagocytes (dendritic cells) [10], then for testis Sertoli cells [179].

A detailed study on the role of TAM receptors in local inflammatory status in blood-separated tissues has been performed for TAM−/− triple mutant testis. Careful examination of pro-inflammatory cytokine levels in testicular extracts from TAM−/− mutant mice showed the increase of tumor necrosis factor α (TNF-α), interleukins (IL) IL-1β, IL-6 and I type of interferons (IFN) proteins compared to WT controls [179–181]. A further study of the mechanism underlying TAM-mediated inhibition of TLR signaling has been carried out using the cultured primary Sertoli cells from triple TAM−/− phenotype [179]. Thus, it has been established that stimulation of TLR3 by poly polyanosinic:polycytidylic acid (I:C) in the Sertoli cell resulted in nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) activation and translocation from cytoplasm to the nucleus after the phosphorylation of its p65 subunit. Compared to WT animals, TAM−/− Sertoli cells exhibited an elevated level of phosphorylated p65. Then, incubation with GAS6 significantly decreased poly (I:C)-induced p65 phosphorylation in control Sertoli cells, but not in TAM−/− ones. As for other cell types, in Sertoli cells, TLR3 triggers the TIR domain-containing adapter-inducing interferon β (TRIF)-dependent pathway that leads to activation of IRF3 via its phosphorylation [179–181]. Pretreatment with TAM ligand GAS6 significantly inhibited interferon regulatory factor 3 (IRF3) phosphorylation in Sertoli cells from the WT control, but not from TAM−/− mice.

Further studies by the same authors demonstrated that TAM modulated inflammatory cytokine production by Sertoli cells [179–181]. Thus, upon the stimulation by poly (I:C), TAM−/− mice upregulated TLR3-driven inflammatory cytokines IL-1β, IL-6 and TNF-α, as well as the production of IFN-α and IFN-β compared to control animals. Moreover, TAM ligand GAS6 inhibited poly (I:C)-induced cytokine production in the WT control, but not in TAM−/− Sertoli cells [179–181]. Finally, in the Sertoli cells, the negative mechanism of TLRs modulation by TAM relies upon the expression of the suppressor of cytokine signalling (SOCSs) factors. Both SOSC1 and SOSC3 factors that mediate TAM inhibition of TLR signaling in professional phagocytes [10] were decreased in Sertoli cells from TAM−/− mice and did not exhibit any response to GAS6 stimulation. On the contrary, in control Sertoli cells, the expression of both suppressor molecules enhanced by up to 60-fold in the presence of poly (I:C) and TAM ligand. As expected, GAS6 induced phosphorylation of transcription factor signal transducer and activator of transcription 1 protein (STAT1) that controls SOCS expression in WT, but not in TAM−/− mice [10]. Because SOCSs also inhibit the TLR-triggered myeloid differentiation protein 88 (MyD88) pathway, activated upon the recruitment of all TLRs except TLR3, the GAS6-induced effect on TLR signaling was
assessed using TLR4 ligand LPS. Of note is that in the case of TLRs, the signaling molecules MyD88 and TRIF was dispensable for LAP [182]. Obviously, LPS-induced proinflammatory cytokine induction was significantly suppressed by GAS6 [179]. Collectively, the data suggest that TAM receptors inhibit both the TLR-triggered MyD88-dependent and TRIF-dependent pathways in Sertoli cells.

It should be noted that the cytokines exert direct effects on active endocrine tissues and are produced by them in noteworthy concentrations [183,184]. Thus, under physiological conditions, TNF-α, IL-1α, IL-1β and IL-6 are continuously expressed in the testis, without inducing any inflammation, but regulating spermatogenesis on different levels [185,189–197]. In the ovary, cytokines TNF-α, interleukins IL-1β-6, -8 and others [198–200] promote follicular growth, steroidogenesis, recruitment and activation of leukocytes necessary for ovulation and tissue remodeling during ovulation, luteinization and luteolysis [198–201]. When upregulated, they negatively affect spermatogenesis and oogenesis, leading to infertility inducing germ cell apoptosis, impairment of blood barriers, immune cell infiltration and the production of autoantibodies [202–206].

To our knowledge, no such detailed study on MERTK-mediated inhibition of TLR signaling in blood-separated retina and ovaries is available to date. MERTK was shown to be important for the inhibition of inflammation in macrophages [207] and macrophage-like cell lines [208] by driving the downregulation of LPS-induced production of TNF-α and IL-6, by triggering PI3K/protein kinase B (AKT) and NF-κB pathways. In M2c anti-inflammatory macrophages, the Mer/Gas6 axis can prevent the release of proinflammatory cytokines and can induce the expression of anti-inflammatory mediators [209,210]. In degenerative RCS rat retinas (mutation of MERTK), increased pro-inflammatory cytokines and activation of microglia were detected starting from early stages of retinal degeneration, supporting the role of MERTK in the regulation of the TLR-mediated inflammatory response [211,212]. Increased inflammatory status is also associated with ARMD—a leading cause of vision loss in elderly individuals. The decline of MERTK-mediated phagocytic activity of RPE is currently considered one of the major factors contributing to this multifactorial pathology [213,214].

Interestingly, alike Sertoli cells and GC [215-217], TLR3 and TLR4 are also expressed at the highest levels in RPE [218]. As suggested, TLR3 might contribute to the clearance of degenerating photoreceptor cells during pathological states in the retina. In these cases, TLRs are thought to be activated by RNAs released from degraded photoreceptors [219]. However, as with other cell types [220], activation of TLR3 in RPE cells triggers their own apoptosis, thereby enhancing a deleterious effect for the retina. To date, it is not clear whether TLR3 contributes to POS phagocytosis in non-pathological situations. On the contrary, in vitro, TLR4 facilitates the phagocytosis of POS by generating transmembrane metabolic and calcium signals that contribute to POS ingestion. In the RPE-retina interface, TLR4 clusters at the sites of contact of POS with MERTK, CD36 and integrins, forming the supra-molecular complex, where each receptor plays a particular role to provide substrate clearance. According to the authors, the role of CD36 is to be a participatory recognition molecule, and the role of MERTK is to be a phagocytosis signaling molecule, while TLR4 is an activating stimulus, specific to the molecular pattern of POS [221]. To what extent such a model can explain the regulatory axis between MERTK-mediated phagocytosis and TLR-mediated inflammation is to be discussed, taking into consideration that, in macrophages, TLR4 triggers the non-inflammatory LAP mechanism [182].

**13. Conclusions**

Timely and efficient elimination of apoptotic substrates, continuously produced during one's lifespan, is a vital need for all tissues of the body. In blood-separated tissues, local non-professional phagocytes cells combine various mechanisms allowing the maintenance of tissue homeostasis and the avoidance of acute inflammation, tissue disorganization and functional ablation. A deeper knowledge of regulatory mechanisms supporting tight cooperation between TAM RTKs and TLR receptors, autophagy-related proteins and LAP
will contribute to providing important basic resources to counteract several vision and reproduction pathologies.

**Author Contributions**

M.G.Y. and B.J.; methodology, M.G.Y., C.R., N.B; software, N.B., A.D.R.; validation, M.G.Y., N.B., C.R., B.J.; formal analysis M.G.Y.; investigation M.G.Y.; resources C.R., A.D.R., B.J.; data curation M.G.Y.; writing—original draft preparation, M.G.Y. and N.B.; writing—review and editing, M.G.Y. and N.B.; visualization, M.G.Y. and N.B.; supervision, C.R. and B.J.; project administration, B.J.; funding acquisition, C.R., A.D.R, N.B., B.J. All authors have read and agreed to the published version of the manuscript.

**Funding:** This research was funded by Rennes Metropole (AIS 2015) and Agence de BioMédecine. This work was supported by funding from Université de Rennes1, Institut National de la Santé et de la Recherche Médicale (INSERM) and CHU de Rennes.

**Institutional Review Board Statement:** Not applicable.

**Informed Consent Statement:** Not applicable.

**Data Availability Statement:** The data presented in this study are available on request from the corresponding author.

**Acknowledgments:** We thank J.C. Hervé for critical reading of the manuscript. M.G.Y. was welcomed by CHU de Rennes. M.G.Y. acknowledges Direction de la Recherche Clinique du CHU de Rennes, Université de Rennes1 and Institut National de la Santé et de la Recherche Médicale (INSERM).

**Conflicts of Interest:** The authors declare no conflict of interest.

**References**

1. Itoh, M.; Yano, A.; Li, X.; Miyamoto, K.; Takeuchi, Y. Limited uptake of foreign materials by resident macrophages in murine ovarian tissues. *J. Reprod. Immunol.* **1999**, *43*, 55–66. [CrossRef]

2. Penberthy, K.K.; Lysiak, J.J.; Ravichandran, K.S. Rethinking Phagocytes: Clues from the Retina and Testes. *Trends Cell. Biol.* **2018**, *28*, 317–327. [CrossRef]

3. Flannagan, R.S.; Jaumouillé, V.; Grinstein, S. The cell biology of phagocytosis. *Annu. Rev. Pathol.* **2012**, *7*, 61–98. [CrossRef]

4. Uribe-Querol, E.; Rosales, C. Phagocytosis: Our Current Understanding of a Universal Biological Process. *Front. Immunol.* **2020**, *11*, 1066. [CrossRef]

5. Kevany, B.M.; Palczewsky, K. Phagocytosis of retinal rod and cone photoreceptors. *Physiology* **2010**, *25*, 8–15. [CrossRef]

6. Henson, P.M.; Bratton, D.L.; Fadok, V.A. The phosphatidylserine receptor: A crucial molecular switch? *Nat. Rev. Mol. Cell. Biol.* **2001**, *2*, 627–633. [CrossRef]

7. Helming, I.; Winter, J.; Gordon, S. The scavenger receptor CD36 plays a role in cytokine-induced macrophage fusion. *J. Cell. Sci.* **2009**, *122*, 453–459. [CrossRef]

8. Yefimova, M.G.; Messaddeq, N.; Meunier, A.C.; Cantereau, A.; Jegou, B.; Bourmeyster, N. Phagocytosis by Sertoli Cells: Analysis of Main Phagocytosis Steps by Confocal and Electron Microscopy. *Methods Mol. Biol.* **2018**, *1748*, 85–101.

9. Rabinovitch, M. Professional and non-professional phagocytes: An introduction. *Trends Cell Biol.* **1995**, *5*, 85–87. [CrossRef]

10. Lemke, G.; Rothlin, C.V. Immunobiology of the TAM receptors. *Nat. Rev. Immunol.* **2008**, *8*, 327–336. [CrossRef]

11. Nguyen-Legros, J.; Hicks, D. Renewal of photoreceptor outer segments and their phagocytosis by the retinal pigment epithelium. *Int. Rev. Cytol.* **2000**, *196*, 245–313. [PubMed]

12. Bok, D.; Young, R.W. Phagocytic Properties of the Retinal Pigment Epithelium. In *The Retinal Pigment Epithelium*; Zinn, K.M., Marmor, M.F., Eds.; Harvard University Press: Cambridge, MA, USA, 1979; pp. 148–174.

13. Young, R.W. Biological renewal, applications to the eye. *Trans. Ophthalmol. Soc. UK* **1982**, *102*, 42–75.

14. Clermont, Y. Quantitative analysis of spermatogenesis of the rat: A revised model for the renewal of spermatogonia. *Am. J. Anat.* **1962**, *111*, 111–129. [CrossRef] [PubMed]

15. Huckins, C. The morphology and kinetics of spermatogonial degeneration in normal adult rats: an analysis using a simplified classification of the germinal epithelium. *Anat. Rec.* **1978**, *190*, 905–926. [CrossRef] [PubMed]

16. Blanco-Rodriguez, J.; Martinez-Garcia, C. Apoptosis is physiologically restricted to a specialized cytoplasmic compartment in rat spermatids. *Biol. Reprod.* **1999**, *61*, 1541–1547. [CrossRef] [PubMed]

17. Pineau, C.; Le Magueresse, B.; Courtens, J.L.; Jégou, B. Study in vitro of the phagocytic function of Sertoli cells in the rat. *Cell Tissue Res.* **1991**, *264*, 589–598. [CrossRef] [PubMed]
18. Panneerdoss, S.; Viswanadhapalli, S.; Abdelfattah, N.; Onyeagucha, B.C.; Timilsina, S.; Mohammad, T.A.; Chen, Y.; Drake, M.; Vuori, K.; Kumar, T.R.; et al. Cross-talk between miR-471-5p and autophagy component proteins regulates LC3-associated phagocytosis (LAP) of apoptotic germ cells. *Nat. Commun.* **2017**, *8*, 598. [CrossRef] [PubMed]

19. Jégou, B. The Sertoli-germ cell communication network in mammals. *Int. Rev. Cytol.* **1993**, *147*, 25–96.

20. Matsuda, F.; Inoue, N.; Manabe, N.; Ohkura, S. Follicular growth and atresia in mammalian ovaries: Regulation by survival and death of granulosa cells. *J. Reprod. Dev.* **2012**, *58*, 44–50. [CrossRef]

21. Yefimova, M.G.; Lefevre, C.; Bashamboo, A.; Eozenou, C.; Burel, A.; Lavault, M.T.; Meunier, A.C.; Pimentel, C.; Veau, S.; Neyroud, A.S.; et al. Granulosa cells provide elimination of apoptotic oocytes through unconventional autophagy-assisted phagocytosis. *Hum. Reprod.* **2020**, *35*, 1346–1362. [CrossRef]

22. Mork, L.; Maatouk, D.M.; McMahon, J.A.; Guo, J.J.; Zhang, P.; McMahon, A.P.; Capel, B. Temporal differences in granulosa cell specification in the ovary reflect distinct follicle fates in mice. *Biol. Reprod.* **2012**, *86*, 37. [CrossRef] [PubMed]

23. Mizushima, N.; Levine, B.; Cuervo, A.M.; Klionsky, D.J. Autophagy fights disease through cellular self-digestion. *Nature* **2008**, *451*, 1069–1075. [CrossRef]

24. Klionsky, D.J.; Abdelmohsen, K.; Abe, A.; Abedin, M.J.; Abeliovich, H.; Acevedo Arozena, A.; Adachi, H.; Adams, C.M.; Adams, P.D.; Adams, C.M.; et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). *Autophagy* **2016**, *12*, 1–222. [CrossRef]

25. Boya, P.; Esteban-Martínez, L.; Serrano-Puebla, A.; Gómez-Sintes, R.; Villarejo-Zori, B. Autophagy in the eye: Development, degeneration, and aging. *Prog. Retin. Eye Res.* **2016**, *55*, 206–245. [CrossRef]

26. Ravikumar, B.; Sarkar, S.; Davies, J.E.; Futter, M.; Garcia-Arencibia, M.; Green-Thompson, Z.W.; Jimenez-Sanchez, M.; Korolchuk, V.I.; Lichtenberg, M.; Luo, S.; et al. Regulation of mammalian autophagy in physiology and pathophysiology. *Physiol. Rev.* **2010**, *90*, 1383–1435. [CrossRef] [PubMed]

27. Delgado, M.A.; Deretic, V. Toll-like receptors in control of immunological autophagy. *Cell Death Diff.* **2009**, *16*, 976–983. [CrossRef]

28. Wirawan, E.; Vanden Berghe, T.; Lippens, S.; Agostinis, P.; Vandenabeele, P. Autophagy: For better or for worse. *Cell Res.* **2012**, *22*, 43–61. [CrossRef] [PubMed]

29. Ohsumi, Y. Historical landmarks of autophagy research. *Cell Res.* **2014**, *24*, 9–23. [CrossRef]

30. Hurley, J.H.; Young, L.N. Mechanisms of Autophagy Initiation. *Annu. Rev. Biochem.* **2017**, *86*, 225–244. [CrossRef]

31. Pattingre, S.; Tassa, A.; Qu, X.; Garuti, R.; Liang, X.H.; Mizushima, N.; Packer, M.; Schneider, M.D.; Levine, B. Bcl-2 antiapoptotic proteins inhibit Beclin 1- dependent autophagy. *Cell* **2005**, *122*, 927–939. [CrossRef]

32. Wei, Y.; Pattingre, S.; Sinha, S.; Bassik, M.; Levine, B. JNK1-mediated phosphorylation of Bcl-2 regulates starvation-induced autophagy. *Mol. Cell* **2008**, *30*, 678–688. [CrossRef]

33. Shi, C.S.; Kehrl, J.H. MyD88 and Trif target Beclin 1 to trigger autophagy in macrophages. *J. Biol. Chem.* **2008**, *283*, 33175–33182. [CrossRef]

34. Sarkar, S. Regulation of autophagy by mTOR-dependent and mTOR-independent pathways: Autophagy dysfunction in neurodegenerative diseases and therapeutic application of autophagy enhancers. *Biochem. Soc. Trans.* **2013**, *41*, 1103–1130. [CrossRef]

35. Wang, A.L.; Lukas, T.J.; Yuan, M.; Du, N.; Tso, M.O.; Neufeld, A.H. Autophagy and exosomes in the aged retinal pigment epithelium: Possible relevance to drusen formation and age-related macular degeneration. *PLoS ONE* **2009**, *4*, e4160. [CrossRef]

36. Mitter, S.K.; Rao, H.V.; Qi, X.; Cai, J.; Sugrue, A.; Dunn, W.A., Jr.; Grant, M.B.; Boulton, M.E. Autophagy in the retina: A potential role in age-related macular degeneration. *Adv. Exp. Med. Biol.* **2012**, *723*, 83–90.

37. Chen, Y.; Sawada, O.; Kohno, H.; Le, Y.Z.; Subauste, C.; Maeda, T.; Maeda, A. Autophagy protects the retina from light-induced degeneration. *J. Biol. Chem.* **2013**, *288*, 7506–7518. [CrossRef]

38. Kaarniranta, K.; Sinha, D.; Blasiak, J.; Kauppinen, A.; Veréb, Z.; Salminen, A.; Boulton, M.E.; Petrovski, G. Autophagy and heterophagy dysregulation leads to retinal pigment epithelium dysfunction and development of age-related macular degeneration. *Autophagy.* **2013**, *9*, 973–984. [CrossRef]

39. Lin, W.; Xu, G. Autophagy: A Role in the Apoptosis, Survival, Inflammation, and Development of the Retina. *Ophthalmic Res.* **2019**, *61*, 65–72. [CrossRef]

40. Flores-Bellver, M.; Bonet-Ponce, L.; Barcia, J.M.; Garcia-Verdugo, J.M.; Martinez-Gil, N.; Saez-Atienzar, S.; Sancho-Pelluz, J.; Jordan, J.; Galindo, M.F.; Romero, F.J. Autophagy and mitochondrial alterations in human retinal pigment epithelial cells induced by ethanol: Implications of 4-hydroxy-nonenal. *Cell Death Dis.* **2014**, *5*, e1328. [CrossRef]

41. Zhu, Y.; Zhao, K.K.; Tong, Y.; Zhou, Y.L.; Wang, Y.X.; Zhao, P.Q.; Wang, Z.Y. Exogenous NAD(+) decreases oxidative stress and protects H2O2-treated RPE cells against necrotic death through the up-regulation of autophagy. *Sci. Rep.* **2016**, *31*, 26322. [CrossRef] [PubMed]

42. Liu, J.; Copland, D.A.; Theodoropoulou, S.; Chiu, H.A.; Barba, M.D.; Mak, K.W.; Mack, M.; Nicholson, L.B.; Dick, A.D. Impairing autophagy in retinal pigment epithelium leads to inflammasome activation and enhanced macrophage-mediated angiogenesis. *Sci. Rep.* **2016**, *6*, 20639. [CrossRef]

43. Corcelle, E.; Nebout, M.; Bekri, S.; Gauthier, N.; Hofman, P.; Poujeol, P.; Fénichel, P.; Mograbi, B. Disruption of autophagy at the maturation step by the carcinogen lindane is associated with the sustained mitogen-activated protein kinase/extracellular signal-regulated kinase activity. *Cancer Res.* **2006**, *66*, 6861–6870. [CrossRef]
44. Yefimova, M.G.; Messaddeq, N.; Harnois, T.; Meunier, A.C.; Clarhaut, J.; Noblanc, A.; Weickert, J.L.; Cantereau, A.; Philippe, M.; Bourmeyster, N.; et al. A Chimerical phagocytosis model reveals the recruitment by Sertoli cells of autophagy for the degradation of ingested illegitimated substrate. *Autophagy* **2013**, *9*, 653–666. [CrossRef] [PubMed]

45. Ma, Y.; Yang, H.Z.; Xu, L.M.; Huang, Y.R.; Dai, H.L.; Kang, X.N. Testosterone regulates the autophagic clearance of androgen-binding protein in rat Sertoli cells. *Sci. Rep.* **2015**, *5*, 8894. [CrossRef]

46. Liu, C.; Wang, H.; Shang, Y.; Liu, W.; Song, Z.; Zhao, H.; Wang, L.; Jia, P.; Gao, F.; Xu, Z.; et al. Autophagy is required for ectoplasmic specialization assembly in sertoli cells. *Autophagy* **2016**, *12*, 814–832. [CrossRef]

47. Horibe, A.; Eid, N.; Ito, Y.; Hamaoka, H.; Tanaka, Y.; Kondo, Y. Upregulated Autophagy in Sertoli Cells of Ethanol-Treated Rats Is Associated with Induction of Inducible Nitric Oxide Synthase (iNOS), Androgen Receptor Suppression and Germ Cell Apoptosis. *Int. J. Mol. Sci.* **2017**, *18*, 1061. [CrossRef]

48. Horibe, A.; Eid, N.; Ito, Y.; Otsuki, Y.; Kondo, Y. Ethanol-Induced Autophagy in Sertoli Cells Is Specifically Marked at Androgen-Dependent Stages of the Spermatogenic Cycle: Potential Mechanisms and Implications. *Int. J. Mol. Sci.* **2019**, *20*, 184. [CrossRef]

49. Zhou, J.; Peng, X.; Mei, S. Autophagy in Ovarian Follicular Development and Atresia. *Int. J. Biol. Sci.* **2019**, *15*, 726–737. [CrossRef]

50. Song, Z.H.; Yu, H.Y.; Wang, P.; Mao, G.K.; Liu, W.X.; Li, M.N.; Wang, H.N.; Shang, Y.L.; Liu, C.; Xu, Z.L.; et al. Germ cell-specific Atg7 knockout results in primary ovarian insufficiency in female mice. *Cell Death Dis.* **2015**, *6*, e1589. [CrossRef]

51. Choi, J.Y.; Jo, M.W.; Lee, E.Y.; Yoon, B.K.; Choi, D.S. The role of autophagy in follicular development and atresia in rat granulosa cells. *Fertil. Steril.* **2010**, *93*, 2532–2537. [CrossRef]

52. Shen, M.; Jiang, Y.; Guan, Z.; Cao, Y.; Li, L.; Liu, H.; Sun, S.C. Protective mechanism of FSH against oxidative damage in mouse ovarian granulosa cells by repressing autophagy. *Autophagy* **2017**, *13*, 1364–1385. [CrossRef]

53. Duerrschmidt, N.; Zabirnyk, O.; Nowicki, M.; Ricken, A.; Hmeidan, F.A.; Blumenauer, V.; Borlak, J.; Spanel-Borowski, K. Lectin-like oxidized low-density lipoprotein receptor-1-mediated autophagy in human granulosa cells as an alternative of programmed cell death. *Endocrinology* **2006**, *147*, 3851–3860. [CrossRef]

54. Choi, J.; Jo, M.; Lee, E.; Choi, D. AKT is involved in granulosa cell autophagy regulation via mTOR signaling during rat follicular development and atresia. *Reproduction* **2013**, *147*, 73–80. [CrossRef]

55. Heckmann, B.L.; Green, D.R. LC3-associated phagocytosis at a glance. *J. Cell Sci.* **2019**, *132*, jcs222984. [CrossRef]

56. Heckmann, B.L.; Teubner, B.J.W.; Tummers, B.; Boada-Romero, E.; Harris, L.; Yang, M.; Guy, C.S.; Zakharenko, S.S.; Green, D.R. LC3-Associated Endocytosis Facilitates β-Amyloid Clearance and Mitigates Neurodegeneration in Murine Alzheimer's Disease. *Cell* **2019**, *178*, 536–551. [CrossRef]

57. Duran, J.M.; Anjard, C.; Stefan, C.; Loomis, W.F.; Malhotra, V. Unconventional secretion of Acb1 is mediated by autophagosomes. *J. Cell Biol.* **2010**, *188*, 527–536. [CrossRef]

58. Manjithaya, R.; Anjard, C.; Loomis, W.F.; Subramani, S. Unconventional secretion of Pichia pastoris Acb1 is dependent on GRASP protein, peroxisomal functions, and autophagosome formation. *J. Cell Biol.* **2010**, *188*, 537–546. [CrossRef] [PubMed]

59. Dupont, N.; Jiang, S.; Pilli, M.; Ornatowski, W.; Bhattacharya, D.; Deretic, V. Autophagybased unconventional secretory pathway for extracellular delivery of IL-1beta. *EMBO J.* **2011**, *30*, 4701–4711. [CrossRef] [PubMed]

60. Bruns, C.; McCaffery, J.M.; Curwin, A.J.; Duran, J.M.; Malhotra, V. Biogenesis of a novel compartment for autophagosome-mediated unconventional protein secretion. *J. Cell Biol.* **2011**, *195*, 979–992. [CrossRef] [PubMed]

61. Cruz-Garcia, D.; Curwin, A.J.; Popoff, J.F.; Bruns, C.; Duran, J.M.; Malhotra, V. Remodeling of secretory compartments creates CUPS during nutrient starvation. *J. Cell Biol.* **2014**, *207*, 695–703. [CrossRef] [PubMed]

62. Li, Y.; Wang, L.X.; Yang, G.; Hao, F.; Urba, W.J.; Hu, H.M. Efficient cross-presentation depends on autophagy in tumor cells. *Cancer Res.* **2008**, *68*, 6889–6895. [CrossRef] [PubMed]

63. Uhl, M.; Kepp, O.; Jusforgues-Saklani, H.; Vicencio, J.M.; Kroemer, G.; Albert, M.L. Autophagy within the antigen donor cell facilitates efficient antigen cross-priming of virus-specific CD8+T cells. *Cell Death Differ.* **2009**, *16*, 991–1005. [CrossRef]

64. Yi, Y.; Zhou, Z.; Shu, S.; Fang, Y.; Twitty, C.; Hilton, T.L.; Aung, S.; Urba, W.J.; Fox, B.A.; Hu, H.M.; et al. Autophagy-assisted antigen cross-presentation: Autophagosome as the argo of shared tumor-specific antigens and DAMPs. *Oncoimmunology* **2012**, *1*, 976–978. [CrossRef] [PubMed]

65. Bourne, M.C.; Campbell, D.A.; Tansley, K. Hereditary degeneration of rat retina. *Br. J. Ophthalmol.* **1938**, *22*, 613–623. [CrossRef] [PubMed]

66. Edwards, R.B.; Szamier, R.B. Defective phagocytosis of isolated rod outer segments by RCS rat retinal pigment epithelium in culture. *Science* **1977**, *197*, 1001–1003. [CrossRef]

67. LaVail, M.M.; Battelle, B.A. Influence of eye pigmentation and light deprivation on inherited retinal dystrophy in the rat. *Exp. Eye Res.* **1975**, *21*, 167–192. [CrossRef]

68. Matthes, M.T.; LaVail, M.M. Inherited retinal dystrophy in the RCS rat: Composition of the outer segment debris zone. *Prog. Clin. Biol. Res.* **1989**, *314*, 315–330.

69. Tso, M.O.; Zhang, C.; Abler, A.S.; Chang, C.J.; Wong, F.; Chang, G.Q.; Lam, T.T. Apoptosis leads to photoreceptor degeneration in inherited retinal dystrophy of RCS rats. *Investig. Ophthalmol. Vis. Sci.* **1994**, *35*, 2693–2699.

70. Mullen, R.J.; LaVail, M.M. Inherited retinal dystrophy: Primary defect in pigment epithelium determined with experimental rat chimeras. *Science* **1976**, *192*, 799–801. [CrossRef]

71. Roque, R.S.; Imperial, C.J.; Caldwell, R.B. Microglial cells invade the outer retina as photoreceptors degenerate in Royal College of Surgeons rats. *Investig. Ophthalmol. Vis. Sci.* **1996**, *37*, 196–203.
72. Vollrath, D.; Feng, W.; Duncan, J.L.; Yasumura, D.; D'Cruz, P.M.; Chappelow, A.; Matthes, M.T.; Kay, M.A.; LaVail, M.M. Correction of the retinal dystrophy phenotype of the RCS rat by viral gene transfer of Mertk. *Proc. Natl. Acad. Sci. USA* **2001**, *98*, 12584–12589. [CrossRef] [PubMed]

73. Yefimova, M.G.; Jeanny, J.C.; Keller, N.; Sergeant, C.; Guillonneau, X.; Beaumont, C.; Courtois, Y. Impaired retinal iron homeostasis associated with defective phagocytosis in Royal College of Surgeons rats. *Investig. Ophthalmol. Vis. Sci.* **2002**, *43*, 537–545.

74. Yefimova, M.G.; Jeanny, J.C.; Guillonneau, X.; Keller, N.; Nguyen-Legros, J.; Sergeant, C.; Guillou, F.; Courtois, Y. Iron, ferritin, transferrin, and transferrin receptor in the adult rat retina. *Investig. Ophthalmol. Vis. Sci.* **2000**, *41*, 2343–2351.

75. Bigot, K.; Gondouin, P.; Bénard, R.; Montagne, P.; Youale, J.; Piazza, M.; Picard, E.; Bordet, T.; Behar-Cohen, F. Transferrin Non-Viral Gene Therapy for Treatment of Retinal Degeneration. *Pharmaceutics* **2020**, *12*, 836. [CrossRef]

76. Lashay, A.; Mahmoudzadeh, R.; Heidari Keshel, S.; Naderi, A.; Omidi, R.; Asadi Amoli, F. Role of Schwann Cells in Preservation of Retinal Tissue Through Reduction of Oxidative Stress. *Med. Hypothesis* *Discov. Innov. Ophthalmol.* **2019**, *8*, 323–332. [PubMed]

77. Picard, E.; Le Rouzic, Q.; Oudar, A.; Berdugo, M.; El Sanharawi, M.; Andrieu-Soler, C.; Naud, M.C.; Jonet, L.; Latour, C.; Klein, C.; et al. Targeting iron-mediated retinal degeneration by local delivery of transferrin. *Free Radic. Biol. Med.* **2015**, *89*, 1105–1121. [CrossRef] [PubMed]

78. D'Cruz, P.M.; Yasumura, D.; Weir, J.; Matthes, M.T.; Abderrahim, H.; LaVail, M.M.; Vollrath, D. Mutation of the receptor tyrosine kinase gene mertk in the retinal dystrophic RCS rat. *Hum. Mol. Genet.* **2000**, *9*, 645–651. [CrossRef]

79. Nandrot, E.; Dufour, E.M.; Provost, A.C.; Péquignot, M.O.; Bonnel, S.; Gogat, K.; Marchant, D.; Rouillac, C.; Sépulchre de Condé, B.; Bihoreau, M.T.; et al. Homozygous deletion in the coding sequence of the c-mer gene in RCS rats unravels general mechanisms of physiological cell adhesion and apoptosis. *Neurobiol. Dis.* **2000**, *7*, 586–599. [CrossRef]

80. Nandrot, E.F.; Dufour, E.M. Mertk in daily retinal phagocytosis: A history in the making. *Adv. Exp. Med. Biol.* **2010**, *664*, 133–140.

81. Duncan, J.L.; LaVail, M.M.; Yasumura, D.; Matthes, M.T.; Yang, H.; Trautmann, N.; Chappelow, A.V.; Feng, W.; Earp, H.S.; Matsushima, G.K.; et al. An RCS-like retinal dystrophy phenotype in mer knockout mice. *Investig. Ophthalmol. Vis. Sci.* **2003**, *44*, 826–838. [CrossRef]

82. Gal, A.; Li, Y.; Thompson, D.A.; Weir, J.; Orth, U.; Jacobson, S.G.; Apfelstedt-Sylla, E.; Vollrath, D. Mutations in MERTK, the human orthologue of the RCS rat retinal dystrophy gene, cause retinitis pigmentosa. *Nat. Genet.* **2000**, *26*, 270–271. [CrossRef]

83. Tschernutter, M.; Jenkins, S.A.; Waseem, N.H.; Saihan, Z.; Holder, G.E.; Bird, A.C.; Bhattacharya, S.S.; Ali, R.R.; Webster, A.R. Clinical characterisation of a family with retinal dystrophy caused by mutation in the Mertk gene. *Br. J. Ophthalmol.* **2006**, *90*, 718–723. [CrossRef]

84. Lu, Q.; Gore, M.; Zhang, Q.; Camenish, T.; Boast, S.; Casagranda, F.; Lai, C.; Skinner, M.K.; Klein, R.; Matsushima, G.K.; et al. Tyro-3 family receptors are essential regulators of mammalian spermatogenesis. *Nature* **1999**, *398*, 723–728. [CrossRef]

85. Xiong, W.; Chen, Y.; Wang, H.; Wang, H.; Wu, H.; Lu, Q.; Han, D. Gas6 and the Tyro3 receptor tyrosine kinase subfamily regulate the phagocytosis function of Sertoli cells. *Reproduction* **2008**, *135*, 77–87. [CrossRef] [PubMed]

86. Chen, Y.; Wang, H.; Qi, N.; Wu, H.; Xiong, W.; Ma, J.; Lu, Q.; Han, D. Functions of TAM RTKs in regulating spermatogenesis and male fertility in mice. *Reproduction* **2009**, *138*, 655–666. [CrossRef] [PubMed]

87. Jégou, B. The Sertoli cell in vivo and in vitro. *Cell Biol. Toxicol.* **1992**, *8*, 49–54. [CrossRef]

88. Wang, F.; Han, D. Sertoli cell phagocytosis: an essential event for spermatogenesis. In *Male reproductive health*; Wu, W., Ziglioli, F., Maestroni, U., Eds.; IntechOpen: London, UK, 2019; pp. 69–84.

89. Burstyn-Cohen, T.; Maimon, A. TAM receptors, Phosphatidylserine, inflammation, and Cancer. *Cell Commun. Signal* **2019**, *17*, 156. [CrossRef] [PubMed]

90. Xiong, W.; Wang, H.; Wu, H.; Chen, Y.; Han, D. Apoptotic spermatogenic cells can be energy sources for Sertoli cells. *Reproduction* **2009**, *137*, 469–479. [CrossRef]

91. Mruk, D.D.; Cheng, C.Y. Sertoli–Sertoli and Sertoli–germ cell interactions and their significance in germ cell movement in the seminiferous epithelium during spermatogenesis. *Endocr. Rev.* **2004**, *25*, 747–806. [CrossRef]

92. Hatzirodos, N.; Hummitzsch, K.; Irving-Rodgers, H.F.; Harland, M.L.; Morris, S.E.; Rodgers, R.J. Transcriptome profiling of granulosa cells from bovine ovarian follicles during atresia. *BMC Genom.* **2014**, *15*, 40. [CrossRef]

93. Dai, W.; Pan, H.; Hassanain, H.; Gupta, S.L.; Murphy, M.J., Jr. Molecular cloning of a novel receptor tyrosine kinase, tif, highly expressed in human ovary and testis. *Oncogene* **1994**, *9*, 975–979.

94. Varnum, B.C.; Young, C.; Elliott, G.; Garcia, A.; Bartley, T.D.; Fridell, Y.W.; Hunt, R.W.; Trail, G.; CloGCton, C.; Toso, R.J.; et al. Axl receptor tyrosine kinase stimulated by the vitamin K-dependent protein encoded by growth arrest-specific gene 6. *Nature* **1995**, *373*, 623–626. [CrossRef] [PubMed]

95. Strick, D.J.; Vollrath, D. Focus on molecules: MERTK. *Exp. Eye Res.* **2010**, *91*, 786–787. [CrossRef] [PubMed]

96. Scott, R.S.; McMahon, E.J.; Pop, S.M.; Reap, E.A.; Caricchio, R.; Cohen, P.L.; Earp, H.S.; Matsushima, G.K. Phagocytosis and clearance of apoptotic cells is mediated by MER. *Nature* **2001**, *411*, 207–211. [CrossRef] [PubMed]

97. Seitz, H.M.; Camenisch, T.D.; Lemke, G.; Earp, H.S.; Matsushima, G.K. Macrophages and dendritic cells use different Axl/Mertk/Tyro3 receptors in clearance of apoptotic cells. *J. Immunol.* **2007**, *178*, 5635–5642. [CrossRef]

98. Van der Meer, J.H.; van der Poll, T.; van 't Veer, C. TAM receptors, Gas6, and protein S: Roles in inflammation and hemostasis. *Blood* **2014**, *123*, 2460–2469. [CrossRef]
99. Cohen, P.L.; Caricchio, R.; Abraham, V.; Camenish, T.D.; Jennette, J.C.; Roubey, R.A.S.; Earp, H.H.S.; Matsushima, G.; Reap, E. Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase. *J. Exp. Med.* **2002**, *196*, 135–140. [CrossRef] [PubMed]

100. Grommes, C.; Lee, C.Y.D.; Wilkinson, B.L.; Jiang, Q.; Koenigcknecht-Talboo, J.L.; Varnum, B.; Landreth, G.E. Regulation of microglial phagocytosis and inflammatory gene expression by GAS6, acting on the Axl/Mer family of tyrosine kinases. *J. Neuroimmune Pharmacol.* **2008**, *3*, 130–140. [CrossRef]

101. Hafizi, S.; Dahlbäck, B. Gas6 and protein S. Vitamin K-dependent ligands for the Axl receptor tyrosine kinase subfamily. *FEBS J.* **2006**, *273*, 5231–5244. [CrossRef]

102. Pierce, A.; Bliesner, B.; Xu, M.; Nielsen-Preiss, S.; Lemke, G.; Tobet, S.; Wierman, M.E. Axl and Tyro3 modulate female reproduction by influencing gonadotropin-releasing hormone neuron survival and migration. *Mol. Endocrinol.* **2008**, *22*, 2481–2495. [CrossRef]

103. Salian-Mehta, S.; Xu, M.; Wierman, M.E. AXL and MET crosstalk to promote gonadotropin releasing hormone (GnRH) neuronal cell migration and survival. *Mol. Cell. Endocrinol.* **2013**, *374*, 92–100. [CrossRef] [PubMed]

104. Salian-Mehta, S.; Xu, M.; Pierce, A.; Bliesner, B.; Tobet, S.; Wierman, M.E. Loss of Growth arrest specific gene 6 (Gas6) results in altered GnRH neuron migration, delayed vaginal opening and sexual maturation in mice. *Mol. Cell. Endocrinol.* **2014**, *393*, 164–170. [CrossRef] [PubMed]

105. Linger, R.M.A.; Keating, A.K.; Earp, H.S.; Graham, D.K. TAM receptor tyrosine kinases: Biologic functions, signaling, and potential therapeutic targeting in human cancer. *Adv. Canc. Res.* **2008**, *100*, 35–83.

106. Nagata, K.; Ohashi, K.; Nakano, T.; Arita, H.; Zong, C.; Hanafusa, H.; Mizuno, K. Identification of the product of growth arrest-specific gene 6 as a common ligand for Axl, Sky, and Mer receptor tyrosine kinases. *J. Biol. Chem.* **1996**, *271*, 30022–30027. [CrossRef]

107. Caberoy, N.B. Synergistic interaction of tubby and tubby-like protein 1 (Tulp1). *Adv. Exp. Med. Biol.* **2014**, *801*, 503–509.

108. Caberoy, N.B.; Alvarado, G.; Bigcas, J.L.; Li, W. Galectin-3 is a new MerTKspecific eat-me signal. *J. Cell Phys.* **2012**, *227*, 401–407. [CrossRef]

109. Nagata, S.; Suzuki, J.; Segawa, K.; Fujii, T. Exposure of phosphatidylserine on the cell surface. *Cell Death Differ.* **2016**, *23*, 952–961. [CrossRef]

110. North, M.A.; Naggert, J.K.; Yan, Y.; Noben-Trauth, K.; Nishina, P.M. Molecular characterization of TUB, TULP1 and TULP2 members of a novel tubby gene family and their possible relation to ocular diseases. *Proc. Natl. Acad. Sci. USA* **1997**, *94*, 3128–3133. [CrossRef]

111. Wollina, U.; Schreiber, G.; Görnig, M.; Feldrappe, S.; Burchert, M.; Gabius, H.J. Sertoli cell expression of galectin-1 and -3 and accessible binding sites in normal human testis and Sertoli cell only-syndrome. *Histol. Histopathol.* **1999**, *14*, 779–784.

112. Chan, M.C.; Mather, J.P.; McCray, G.; Lee, W.M. Identification and regulation of receptor tyrosine kinases Rse and Mer and their ligand Gas6 in testicular somatic cells. *J. Androl.* **2000**, *21*, 291–302.

113. Uehara, F.; Ohba, N.; Ozawa, M. Isolation and characterization of galectins in the mammalian retina. *Investig. Ophthalmol. Vis. Sci.* **2001**, *42*, 2164–2172.

114. Deschildre, C.; Li, J.W.; Chater, S.; Dacheux, F.; Selva, J.; Albert, M.; Bailly, M.; Hatey, F.; Benahmed, M. Expression of galectin-3 and its regulation in the testis. *Int. J. Androl.* **2007**, *30*, 28–40. [CrossRef]

115. Kim, M.K.; Sung, C.O.; Do, I.G.; Jeon, H.K.; Song, T.J.; Park, H.S.; Lee, Y.Y.; Kim, B.G.; Lee, J.W.; Bae, D.S. Overexpression of Galectin-3 and its clinical significance in ovarian carcinoma. *Int. J. Clin. Oncol.* **2011**, *16*, 352–358. [CrossRef] [PubMed]

116. Mukhopadhyay, S.; Jackson, P.K. The tubby family proteins. *Genome Biol.* **2011**, *12*, 225. [CrossRef] [PubMed]

117. Nandrot, E.F. Opposite Roles of MerTK Ligands Gas6 and Protein S During Retinal Phagocytosis. *Adv. Exp. Med. Biol.* **2018**, *1074*, 577–583. [PubMed]

118. Kim, K.H.; Kim, E.Y.; Ko, J.J.; Lee, K.A. Gas6 is a reciprocal regulator of mitophagy during mammalian oocyte maturation. *Sci. Rep.* **2019**, *9*, 10343. [CrossRef]

119. Shimada, C.; Xu, R.; Al-Alem, L.; Stasenko, M.; SprigGC, D.R.; Rueda, B.R. Galectins and Ovarian Cancer. *Cancers* **2020**, *12*, 1421. [CrossRef]

120. Prasad, D.; Rothlin, C.V.; Burrola, P.; Burstyn-Cohen, T.; Lu, Q.; Garcia de Frutos, P.; Lemke, G. TAM receptor function in the retinal pigment epithelium. *Mol. Cell. Neurosci.* **2006**, *33*, 96–108. [CrossRef] [PubMed]

121. Burstyn-Cohen, T.; Lew, E.D.; Través, P.G.; Burrola, P.G.; Hash, J.C.; Lemke, G. Genetic dissection of TAM receptor-ligand interaction in retinal pigment epithelial cell phagocytosis. *Neuron* **2012**, *76*, 1123–1132. [CrossRef]

122. Poiriers, F.; Robertson, E.J. Normal development of mice carrying a null mutation in gene encoding the L14 S-type lectin. *Development* **1993**, *119*, 1229–1236. [CrossRef]

123. Ohlemiller, K.K.; Ogilvie, J.M.; Lett, J.M.; Hudges, R.M.; LaRegina, M.C.; Olson, L.M. The murine tub (rd5) mutation is not associated with a primary axonemal defect. *Cell Tissue Res* **1998**, *291*, 489–495. [CrossRef] [PubMed]

124. Strick, D.J.; Feng, W.; Vollrath, D. Mertk drives myosin II redistribution during retinal pigment epithelium phagocytosis. *Investig. Ophthalmol. Vis. Sci.* **2009**, *50*, 2427–2435. [CrossRef] [PubMed]

125. Shelby, S.J.; Feathers, K.L.; Ganios, A.M.; Jia, L.; Miller, J.M.; Thompson, D.A. MERTK signaling in the retinal pigment epithelium regulates the tyrosine phosphorylation of GDP dissociation inhibitor alpha from the GDI/CHM family of RAB GTPase effectors. *Exp. Eye Res.* **2015**, *140*, 28–40. [CrossRef] [PubMed]
126. Vollrath, D.; Yasumura, D.; Benchorin, G.; Matthes, M.T.; Feng, W.; Nguyen, N.M.; Sedano, C.D.; Calton, M.A.; LaVail, M.M. Tyro3 Modulates Mertk-Associated Retinal Degeneration. *PLoS Genet.* **2015**, *11*, e1005723. [CrossRef]

127. Finnemann, S.C.; Silverstein, R.L. Differential roles of CD36 and alphavbeta5 integrin in photoreceptor phagocytosis by the retinal pigment epithelium. *J. Exp. Med.* **2001**, *194*, 1289–1298. [CrossRef] [PubMed]

128. Nandrot, E.F.; Kim, Y.; Brodie, S.E.; Huang, X.; Sheppard, D.; Finnemann, S.C. Loss of synchronized retinal phagocytosis and age-related blindness in mice lacking alphavbeta5 integrin. *J. Exp. Med.* **2004**, *200*, 1539–1545. [CrossRef]

129. Mao, Y.; Finnemann, S.C. Essential diurnal Rac1 activation during retinal phagocytosis requires avb5 integrin but not tyrosine kinases focal adhesion kinase or Mer tyrosine kinase. *Mol. Biol. Cell.* **2012**, *23*, 1104–1114. [CrossRef] [PubMed]

130. Bulloj, A.; Duan, W.; Finnemann, S.C. PI 3-kinase independent role for AKT in F-actin regulation during outer segment phagocytosis by RPE cells. *Exp. Eye Res.* **2013**, *113*, 9–18. [CrossRef]

131. Gillot, I.; Jehi-Petri, C.; Gounon, P.; Luquet, S.; Rassoulzadegan, M.; Grimaldi, P.; Vidal, F. Germ cells and fatty acids induce translocation of CD36 scavenger receptor to the plasma membrane of Sertoli cells. *J. Cell. Sci.* **2005**, *118*, 3027–3035. [CrossRef]

132. Carr, M.E., Jr.; Steingold, K.A.; Zekert, S.L. Protein S levels during the normal menstrual cycle and during estrogen therapy for premature ovarian failure. *Am. J. Med. Sci.* **1993**, *306*, 212–217. [CrossRef]

133. Ensslin, M.A.; Shur, B.D. Identification of mouse sperm SED1, a bimotif EGF repeat and discoidin-domain protein involved in sperm-egg binding. *Cell* **2003**, *114*, 405–417. [CrossRef]

134. Sun, W.; Fujimoto, J.; Tamaya, T. Coexpression of Gas6/Axl in human ovarian cancers. *Oncology* **2004**, *66*, 450–457. [CrossRef] [PubMed]

135. Monniaux, D.; Huet-Calderwood, C.; Le Bellego, F.; Fabre, S.; Monget, P.; Calderwood, D.A. Integrins in the ovary. *Semin. Reprod. Med.* **2006**, *24*, 251–261. [CrossRef] [PubMed]

136. Naka, M.; Kusakabe, K.; Takeshita, A.; Nakagawa, H.; Ito, Y.; Shibata, M.A.; Otsuki, Y. Phagocytosis mechanism of apoptotic granulosa cells regulated by milk-fat globule-EGF factor 8. *Med. Mol. Morphol.* **2009**, *42*, 143–149. [CrossRef]

137. Petrik, J.J.; Gentry, P.A.; Feige, J.J.; LaMarre, J. Expression and localization of thrombospondin-1 and -2 and their cell-surface receptor, CD36, during rat follicular development and formation of the corpus luteum. *Biol. Reprod.* **2002**, *67*, 1522–1531. [CrossRef]

138. Osz, K.; Ross, M.; Petrik, J. The thrombospondin-1 receptor CD36 is an important mediator of ovarian angiogenesis and folliculo-genesis. *Reprod. Biol. Endocrinol.* **2014**, *12*, 21. [CrossRef]

139. Siu, M.K.; Cheng, C.Y. Interactions of proteases, protease inhibitors, and the β1 integrin/laminin protein complex in the regulation of ectoplasmic specialization dynamics in the testis. *Biol. Reprod.* **2004**, *70*, 945–964. [CrossRef]

140. Wong, C.H.; Xia, W.; Lee, N.P.Y.; Mruk, D.D.; Lee, W.M.; Cheng, C.Y. Regulation of ectoplasmic specialization dynamics in the seminiferous epithelium by focal adhesion- associated proteins in testosterone-suppressed rat testis. *Endocrinology* **2005**, *146*, 1192–1204. [CrossRef]

141. Tancioni, I.; Uryu, S.; Sulzmaier, F.J.; Shah, N.R.; Lawson, C.; Miller, N.L.; Jean, C.; Chen, X.L.; Ward, K.K.; Schlaepfer, D.D. FAK Inhibition disrupts αβ5 integrin signaling axis controlling anchorage-independent ovarian carcinoma growth. *Mol. Cancer Ther.* **2014**, *13*, 2050–2061. [CrossRef]

142. Tyasi, T.L.; Sun, X.; Shan, X.; Liswaniso, S.; Chimbaka, I.M.; Qin, N.; Xu, R. Effects of RAC1 on Proliferation of Hen Ovarian Prehierarchical Follicle Granulosa Cells. *Animals* **2020**, *10*, 1589. [CrossRef]

143. Kim, J.Y.; Zhao, H.; Martinez, J.; Doggett, T.A.; Kolesnikov, A.V.; Tang, P.H.; Ablonczy, Z.; Chan, C.C.; Zhou, Z.; Green, D.R.; et al. Noncanonical autophagy promotes the visual cycle. *Cell* **2013**, *154*, 365–376. [CrossRef]

144. Heckmann, B.L.; Boada-Romero, E.; Cunha, L.D.; Magne, J.; Green, D.R. LC3-Associated phagocytosis and inflammation. *J. Mol. Biol.* **2017**, *429*, 3561–3576. [CrossRef]

145. Martinez, J. LAP it up, fuzz ball: A short history of LC3-associated phagocytosis. *Curr. Opin. Immunol.* **2018**, *55*, 54–61. [CrossRef] [PubMed]

146. Martinez, J.; Malireddi, R.K.; Lu, Q.; Cunha, L.D.; Pelletier, S.; Gingras, S.; Orchard, R.; Guan, J.L.; Tan, H.; Peng, J.; et al. Molecular characterization of LC3-associated phagocytosis reveals distinct roles for Rubicon, NOX₂ and autophagy proteins. *Nat. Cell. Biol.* **2015**, *17*, 893–906. [CrossRef]

147. Bandyopadhyay, U.; Overholtzer, M. LAP: The protector against autoimmunity. *Cell Res.* **2016**, *26*, 865–866. [CrossRef] [PubMed]

148. Masud, S.; Prajsnar, T.K.; Torraca, V.; Lamers, G.E.M.; Benning, M.; Van Der Vaart, M.; Meijer, A.H. Macrophages target Salmonella by Lc3-associated phagocytosis in a systemic infection model. *Autophagy* **2019**, *15*, 796–812. [CrossRef] [PubMed]

149. Muniz-Feliciano, L.; Doggett, T.A.; Zhou, Z.; Ferguson, T.A. RUBCN/rubicon and EGFR regulate lysosomal degradative processes in the retinal pigment epithelium (RPE) of the eye. *Autophagy* **2017**, *13*, 2072–2085. [CrossRef] [PubMed]

150. Amer, A.O.; Swanson, M.S. Autophagy is an immediate macrophage response to Legionella pneumophila. *Cell. Microbiol.* **2005**, *7*, 765–778. [CrossRef]

151. Martinez, J.; Almendinger, J.; Oberst, A.; Ness, R.; Dillon, C.P.; Fitzgerald, P.; Hengartner, M.O.; Green, D.R. Microtubule-associated protein 1 light chain 3 alpha (LC3)-associated phagocytosis is required for the efficient clearance of dead cells. *Proc. Natl. Acad. Sci. USA* **2011**, *108*, 17396–17401. [CrossRef]

152. Wirawan, E.; Lippens, S.; Vanden Berghe, T.; Romagnoli, A.; Fimia, G.M.; Piacentini, M.; Vandenabeele, P. Beclin1: A role in membrane dynamics and beyond. *Autophagy* **2012**, *8*, 6–17. [CrossRef]

153. Simon, A.; Clarke, A. Non-canonical autophagy LAPs lupus. *Cell Death Differ.* **2016**, *23*, 1267–1268. [CrossRef]
154. Almedawar, S.; Vafia, K.; Schreiter, S.; Neumann, K.; Khattak, S.; Kurth, T.; Ader, M.; Karl, M.O.; Tsang, S.H.; Tanaka, E.M. MERTK-Dependent Ensheathment of Photoreceptor Outer Segments by Human Pluripotent Stem Cell-Derived Retinal Pigment Epithelium. *Stem. Cell Rep.* **2020**, *3*, 374–389. [CrossRef] [PubMed]

155. Kawasaki, Y.; Nakagawa, A.; Nagaosa, K.; Shiratsuchi, A.; Nakanishi, Y. Phosphatidylserine binding of class B scavenger receptor type I, a phagocytosis receptor of testicular Sertoli cells. *J. Biol. Chem.* **2002**, *277*, 27559–27566. [CrossRef] [PubMed]

156. Nakanishi, Y.; Shiratsuchi, A. Phagocytic removal of apoptotic spermatogenic cells by Sertoli cells: Mechanisms and consequences. *Biol. Pharm. Bull.* **2004**, *27*, 13–16. [CrossRef]

157. Steinberg, R.H.; Wood, I.; Hogan, M.J. Pigment epithelial ensheathment and phagocytosis of extrafoveal cones in human retina. *Philos. Trans. R. Soc. Lond. B Biol. Sci.* **1977**, *277*, 459–471.

158. Myers, K.V.; Amend, S.R.; Pienta, K.J. Targeting Tyro3, Axl and MerTK (TAM receptors): Implications for macrophages in the tumor microenvironment. *Mol. Cancer* **2019**, *18*, 94. [CrossRef] [PubMed]

159. Giroud, P.; Renaudineau, S.; Gudefin, L.; Calcei, A.; Menguy, T.; Rozan, C.; Mizrahi, J.; Caux, C.; Duong, V.; Valladeau-Guilemond, J. Expression of TAM-R in Human Immune Cells and Unique Regulatory Function of MerTK in IL-10 Production by Tolerogenic DC. *Front. Immunol.* **2020**, *11*, 564133. [CrossRef]

160. Kuro-o, M.; Matsumura, Y.; Aizawa, H.; Kawaguchi, H.; Suga, T.; Utsugi, T.; Ohyama, Y.; Kurabayashi, M.; Kaname, T.; Kume, E.; et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. *Nature* **1997**, *390*, 45–51. [CrossRef] [PubMed]

161. Kokkinaki, M.; Abu-Asab, M.; Gunawardena, N.; Ahern, G.; Javidnia, M.; Young, J.; Golestaneh, N. Klotho regulates retinal pigment epithelial functions and protects against oxidative stress. *J. Neurosci.* **2013**, *33*, 16346–16359. [CrossRef] [PubMed]

162. Imura, A.; Iwano, A.; Tohyama, O.; Tsuji, Y.; Nozaki, K.; Hashimoto, N.; Fujimori, T.; Nabeshima, Y. Secreted Klotho protein in sera and CSF: Implication for post-translational cleavage in release of Klotho protein from cell membrane. *FEBS Lett.* **2004**, *565*, 143–147. [CrossRef]

163. Wolf, G. Lipofuscin and macular degeneration. *Nutr. Rev.* **2003**, *61*, 342–346. [CrossRef]

164. Saftari, L.N.; Kwon, O.S. Ageing vision and falls: A review. *J. Physiol. Anthropol.* **2018**, *37*, 11. [CrossRef]

165. Lim, K.; Groen, A.; Molostvov, G.; Lu, T.; Lilley, K.S.; Snead, D.; James, S.; Wilkinson, I.B.; Ting, S.; Hsiao, L.L.; et al. α-Klotho Expression in Human Tissues. *J. Clin. Endocrinol. Metab.* **2015**, *100*, E1308–E1318. [CrossRef] [PubMed]

166. Li, S.A.; Watanabe, M.; Yamada, H.; Nagai, A.; Kinuta, M.; Takei, K. Immunohistochemical localization of Klotho protein in brain, kidney, and reproductive organs of mice. *Cell. Struct. Funct.* **2004**, *29*, 91–99. [CrossRef] [PubMed]

167. Toyama, R.; Fujimori, T.; Nabeshima, Y.; Itoh, Y.; Tsuji, Y.; Osamura, R.Y.; Nabeshima, Y. Impaired regulation of gonadotropins leads to the atrophy of the female reproductive system in klotho-deficient mice. *Endocrinology* **2006**, *147*, 120–129. [CrossRef] [PubMed]

168. Mao, Z.; Fan, L.; Yu, Q.; Luo, S.; Wu, X.; Tang, J.; Kang, G.; Tang, L. Abnormality of Klotho Signaling Is Involved in Polycystic Ovary Syndrome. *Reprod. Sci.* **2018**, *25*, 372–383. [CrossRef] [PubMed]

169. Xu, X.; Hao, Y.; Zhong, Q.; Hang, J.; Zhao, Y.; Qiao, J. Low KLOTHO level related to aging is associated with diminished ovarian reserve. *Fertil. Steril.* **2020**, *114*, 1250–1255. [CrossRef] [PubMed]

170. Liu, T.; Liu, Y.; Huang, Y.; Chen, J.; Yu, Z.; Chen, C.; Lai, L. miR-15b induces premature ovarian failure in mice via inhibition of α-Klotho expression in ovarian granulosa cells. *Free Radic. Biol. Med.* **2019**, *141*, 383–392. [CrossRef]

171. Nelson, L.M. Clinical practice. Primary ovarian insufficiency. *N. Engl. J. Med.* **2009**, *360*, 606–614. [CrossRef]

172. Gleicher, N.; Kushnir, V.A.; Barad, D.H. Prospectively assessing risk for premature ovarian senescence in young females: A new paradigm. *Reprod. Biol. Endocrinol.* **2015**, *13*, 34. [CrossRef]

173. Lu, Q.; Lemke, G. Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family. *Science* **2001**, *293*, 306–311. [CrossRef]

174. Camenisch, T.D.; Koller, B.H.; Earp, H.S.; Matsushima, G.K. A novel receptor tyrosine kinase, Mer, inhibits TNF-alpha production and lipopolysaccharide-induced endotoxic shock. *J. Immunol.* **1999**, *162*, 3498–3503. [PubMed]

175. Rothlin, C.V.; Ghosh, S.; Zuniga, E.I.; Oldstone, M.B.; Lemke, G. TAM receptors are pleiotropic inhibitors of the innate immunity response. *Cell* **2007**, *131*, 1124–1136. [CrossRef] [PubMed]

176. Martinez, J.; Cunha, L.D.; Park, S.; Yang, M.; Lu, Q.; Orchard, R.; Li, Q.Z.; Yan, M.; Janke, L.; Guy, C.; et al. Noncanonical autophagy inhibits the autoinflammatory, lupus-like response to dying cells. *Nature* **2016**, *533*, 115–119. [CrossRef] [PubMed]

177. Asare, P.F.; Roscioli, E.; Hurtado, P.R.; Tran, H.B.; Mah, C.Y.; Hodge, S. LC3-Associated Phagocytosis (LAP): A Potentially Influential Mediator of Efferocytosis-Related Tumor Progression and Aggressiveness. *Front. Oncol.* **2020**, *10*, 1298. [CrossRef]

178. Kyger, M.; Worley, A.; Adamus, G. Autoimmune responses against photoreceptor antigens during retinal degeneration and their role in macrophage recruitment into retinas of RCS rats. *J. Neuroimmunol.* **2013**, *254*, 91–100. [CrossRef] [PubMed]

179. Sun, B.; Qi, N.; Shang, T.; Wu, H.; Deng, T.; Han, D. Sertoli cell-initiated testicular innate immune response through Toll-like receptor-3 activation is negatively regulated by Tyro3, Axl and Mer receptors. *Endocrinology* **2010**, *151*, 2886–2897. [CrossRef] [PubMed]

180. Zhang, Y.; Li, N.; Chen, Q.; Yan, K.; Liu, Z.; Zhang, X.; Liu, P.; Chen, Y.; Han, D. Breakdown of immune homeostasis in the testis of mice lacking Tyro3, Axl and Mer receptor tyrosine kinases. *Immunol. Cell. Biol.* **2013**, *91*, 416–426. [CrossRef]
181. Zhang, X.; Wang, T.; Deng, T.; Xiong, W.; Lui, P.; Li, N.; Chen, Y.; Han, D. Damaged spermatogenic cells induce inflammatory gene expression in mouse Sertoli cells through the activation of Toll-like receptors 2 and 4. *Mol. Cell. Endocrinol.* **2013**, *365*, 162-173.
[CrossRef]

182. Sanjuan, M.A.; Dillon, C.P.; Tait, S.W.; Moshiach, S.; Dorsey, F.; Connell, S.; Komatsu, M.; Tanaka, K.; Cleveland, J.L.; Withoff, S.; et al. Toll-like receptor signaling in macrophages links the autophagy pathway to phagocytosis. *Nature* **2007**, *450*, 1253-1257.
[CrossRef]

183. Mandrup-Poulsen, T.; Nerup, J.; Reimers, J.I.; Pociot, F.; Andersen, H.U.; Karlsen, A.; Bjerre, U.; Bergholdt, R. Cytokines and the endocrine system. I. The immunoendocrine network. *Eur. J. Endocrinol.* **1995**, *133*, 660-671. [CrossRef]

184. Vinatier, D.; Dufour, P.; Tordjeman-Rizzi, N.; Prolongeau, J.F.; Depret-Moser, S.; Monnier, J.C. Immunological aspects of ovarian function: Role of the cytokines. *Eur. J. Obstet. Gynecol. Reprod. Biol.* **1995**, *63*, 155-168. [CrossRef]

185. Dejucq, N.; Dugast, I.; Ruffault, A.; van der Meide, P.H.; Jégou, B. Interferon-alpha and -gamma expression in the rat testis. *Endocrinology* **1995**, *136*, 4925-4931. [CrossRef] [PubMed]

186. Blasius, A.L.; Beutler, B. Intracellular Toll-like receptors. *Immunity* **2010**, *32*, 305-315. [CrossRef] [PubMed]

187. Wang, J.; Hu, Y.; Deng, W.W.; Sun, B. Negative regulation of Toll-like receptor signaling pathway. *Microbes Infect.* **2009**, *11*, 321-327. [CrossRef] [PubMed]

188. Kondo, T.; Kawai, T.; Akira, S. Dissecting negative regulation of Toll-like receptor signaling. *Trends Immunol.* **2012**, *33*, 449-458.
[CrossRef] [PubMed]

189. Jégou, B.; Cudicini, C.; Gomez, E.; Stéphan, J.P. Interleukin-1, interleukin-6 and the germ cell-Sertoli cell cross-talk. *Reprod. Fertil. Dev.* **1995**, *7*, 723-730. [CrossRef] [PubMed]

190. Syed, V.; Stéphan, J.P.; Gérard, N.; Legrand, A.; Parvinen, M.; Bardin, C.W.; Jégou, B. Residual bodies activate Sertoli cell interleukin-1 alpha (IL-1 alpha) release, which triggers IL-6 production by an autocrine mechanism, through the lipoxygenase pathway. *Endocrinology* **1995**, *136*, 3070-3078. [CrossRef]

191. Cudicini, C.; Lejeune, H.; Gomez, E.; Bosmans, E.; Ballet, F.; Saez, J.; Jégou, B. Human Leydig cells and Sertoli cells are producers of interleukins-1 and -6. *J. Clin. Endocrinol. Metab.* **1997**, *82*, 1426-1433. [CrossRef]

192. Dejucq, N.; Chousterman, S.; Jégou, B. The testicular antiviral defense system: Localization, expression, and regulation of 2'5' oligoadenylate synthetase, double-stranded RNA-activated protein kinase, and Mx proteins in the rat seminiferous tubule. *J. Cell. Biol.* **1997**, *139*, 865-873. [CrossRef]

193. Stéphan, J.P.; Syed, V.; Jégou, B. Regulation of Sertoli cell IL-1 and IL-6 production in vitro. *Mol. Cell. Endocrinol.* **1997**, *134*, 109-118. [CrossRef]

194. Dejucq, N.; Lienard, M.O.; Guillaume, E.; Dorval, I.; Jégou, B. Expression of interferons-alpha and -gamma in testicular interstitial tissue and spermatogonia of the rat. *Endocrinology* **1998**, *139*, 3081-3087. [CrossRef] [PubMed]

195. Jégou, B.; Stéphan, J.P.; Cudicini, C.; Gomez, E.; Bauché, F.; Piquet-Pellorce, C.; Touzalin, A.M. The Sertoli cell-germ cell interactions and the seminiferous tubule interleukin-1 and interleukin-6 system. *Results Probl. Cell. Differ.* **2000**, *28*, 53-68.
[PubMed]

196. Dejucq, N.; Jégou, B. Viruses in the mammalian male genital tract and their effects on the reproductive system. *Microbiol. Mol. Biol. Rev.* **2001**, *65*, 208-231. [CrossRef] [PubMed]

197. Li, M.W.M.; Mruk, D.D.; Lee, W.M.; Cheng, C.Y. Cytokines and junction restructuring events during spermatogenesis in the testis: An emerging concept of regulation. *Cytokines Growth Factor Rev.* **2009**, *20*, 329-338. [CrossRef]

198. Bagavant, H.; Adams, S.; Terranova, P.; Chang, A.; Kraemer, F.W.; Lou, Y.; Kasai, K.; Luo, A.M.; Tung, K.S. Autoimmune ovarian inflammation triggered by proinflammatory (Th1) T cells is compatible with normal ovarian function in mice. *Biol. Reprod.* **1999**, *61*, 635-642. [CrossRef]

199. Sarapik, A.; Velthut, A.; Haller-Kikkatalo, K.; Faure, G.C.; Béné, M.C.; de Carvalho Bittencourt, M.; Massin, F.; Uibo, R.; Salumets, A. Follicular proinflammatory cytokines and chemokines as markers of IVF success. *Clin. Dev. Immunol.* **2012**, *2012*, 606459. [CrossRef]

200. Büscher, U.; Chen, F.C.; Kentenich, H.; Schmiady, H. Cytokines in the follicular fluid of stimulated and non-stimulated human ovaries; is ovulation a suppressed inflammatory reaction? *Hum. Reprod.* **1999**, *14*, 162-166. [CrossRef]

201. Warma, A.; Descarreaux, M.; Chorfi, Y.; Dupras, R.; Rémillard, R.; Ndiaye, K. Interleukins' expression profile changes in granulosa cells of preovulatory follicles during the postpartum period in dairy cows. *Cytokine X* **2020**, *2*, 100022. [CrossRef]

202. Suescun, M.O.; Rival, C.; Theas, M.S.; Calandra, R.S.; Lustig, L. Involvement of tumor necrosis factor-α in the pathogenesis of autoimmune orchitis in rats. *Biol. Reprod.* **2003**, *68*, 2114-2121. [CrossRef]

203. Huleihel, M.; Lunenfeld, E. Regulation of spermatogenesis by paracrine/autocrine testicular factors. *Asian J. Androl.* **2004**, *6*, 259-268.

204. Guazzone, V.A.; Jacobo, P.; Theas, M.S.; Lustig, L. Cytokines and chemokines in testicular inflammation: A brief review. *Microsc. Res. Tech.* **2009**, *72*, 620-628. [CrossRef]

205. Rival, C.; Theas, M.S.; Guazzone, V.A.; Lustig, L. Interleukin-6 and IL-6 receptor cell expression in testis of rats with autoimmune orchitis. *J. Reprod. Immunol.* **2006**, *70*, 43-58. [CrossRef] [PubMed]

206. Liu, P.; Zhang, X.; Hu, J.; Cui, L.; Zhao, S.; Jiao, X.; Qin, Y. Dysregulated cytokine profile associated with biochemical premature ovarian insufficiency. *Am. J. Reprod. Immunol.* **2020**, *84*, e13292. [CrossRef] [PubMed]
207. Deng, T.; Zhang, Y.; Chen, Q.; Yan, K.; Han, D. Toll-like receptor-mediated inhibition of Gas6 and ProS expression facilitates inflammatory cytokine production in mouse macrophages. *Immunology* **2012**, *135*, 40–50. [CrossRef] [PubMed]

208. Alciato, F.; Sainaghi, P.P.; Sola, D.; Castello, L.; Avanzi, G.C. TNF-alpha, IL-6, and IL-1 expression is inhibited by GAS6 in monocytes/macrophages. *J. Leukoc. Biol.* **2010**, *5*, 869–875. [CrossRef] [PubMed]

209. Zizzo, G.; Hilliard, B.A.; Monestier, M.; Cohen, P.L. Efficient clearance of early apoptotic cells by human macrophages requires M2c polarization and MerTK induction. *J. Immunol.* **2012**, *189*, 3508–3520. [CrossRef]

210. Pagani, S.; Bellan, M.; Mauro, D.; Castello, L.M.; Avanzi, G.C.; Lewis, M.J.; Sainaghi, P.P.; Pitzalis, C.; Nerviani, A. New Insights into the Role of Tyro3, Axl, and Mer Receptors in Rheumatoid Arthritis. *Dis. Markers.* **2020**, *2020*, 1614627. [CrossRef] [PubMed]

211. Liu, Y.; Yang, X.; Utheim, T.P.; Guo, C.; Xiao, M.; Liu, Y.; Yin, Z.; Ma, J. Correlation of cytokine levels and microglial cell infiltration during retinal degeneration in RCS rats. *PLoS ONE* **2013**, *8*, e82061. [CrossRef]

212. Yoshida, N.; Ikeda, Y.; Notomi, S.; Ishikawa, K.; Murakami, Y.; Hisatomi, T.; Enaida, H.; Ishibashi, T. Laboratory evidence of sustained chronic inflammatory reaction in retinitis pigmentosa. *Ophthalmology* **2013**, *120*, e5–e12. [CrossRef]

213. Ozaki, E.; Campbell, M.; Kiang, A.S.; Humphries, M.; Doyle, S.L.; Humphries, P. Inflammation in age-related macular degeneration. *Adv. Exp. Med. Biol.* **2014**, *801*, 229–235.

214. Inana, G.; Murat, C.; An, W.; Yao, X.; Harris, I.R.; Cao, J. RPE phagocytic function declines in age-related macular degeneration and is rescued by human umbilical tissue derived cells. *J. Transl. Med.* **2018**, *16*, 63. [CrossRef]

215. Riccioli, A.; Starace, D.; Galli, R.; Fuso, A.; Scarpa, S.; Palombi, F.; De Cesaris, P.; Ziparo, E.; Filippini, A. Sertoli cells initiate testicular innate immune responses through TLR activation. *J. Immunol.* **2006**, *177*, 7122–7130. [CrossRef]

216. Wu, H.; Wang, H.; Xiong, W.; Chen, S.; Tang, H.; Han, D. Expression patterns and functions of Toll-like receptors in mouse Sertoli cells. *Endocrinology* **2008**, *149*, 4402–4412. [CrossRef]

217. Ernst, E.H.; Amoushahi, M.; Sørensen, A.S.; KraGCtrup, T.W.; Ernst, E.; Lykke-Hartmann, K. Distinct expression patterns of TLR transcripts in human oocytes and granulosa cells from primordial and primary follicles. *J. Reprod. Immunol.* **2020**, *140*, 103125. [CrossRef] [PubMed]

218. Kumar, M.V.; Nagineni, C.N.; Chin, M.S.; Hooks, J.J.; Detrick, B. Innate immunity in the retina: Toll-like receptor (TLR) signaling in human retinal pigment epithelial cells. *J. Neuroimmunol.* **2004**, *153*, 7–15. [CrossRef]

219. Shiose, S.; Chen, Y.; Okano, K.; Roy, S.; Kohno, H.; Tang, J.; Pearlman, E.; Maeda, T.; Palczewski, K.; Maeda, A. Toll-like receptor 3 is required for development of retinopathy caused by impaired all-trans-retinal clearance in mice. *J. Biol. Chem.* **2011**, *286*, 15543–15555. [CrossRef]

220. Nakamura, H.; Horai, Y.; Suzuki, T.; Okada, A.; Ichinose, K.; Yamasaki, S.; Koji, T.; Kawakami, A. TLR3-mediated apoptosis and activation of phosphorylated Akt in the salivary gland epithelial cells of primary Sjögren's syndrome patients. *Rheumatol. Int.* **2013**, *33*, 441–450. [CrossRef] [PubMed]

221. Kindzelskii, A.L.; Elner, V.M.; Elner, S.G.; Yang, D.; Hughes, B.A.; Petty, H.R. Toll-like receptor 4 (TLR4) of retinal pigment epithelial cells participates in transmembrane signaling in response to photoreceptor outer segments. *J. Gen. Phys.* **2004**, *124*, 139–149. [CrossRef] [PubMed]